Hemodynamic Mechanisms Regulating Inflammatory Vascular Remodeling by Givens, Chris
HEMODYNAMIC MECHANISMS REGULATING INFLAMMATORY VASCULAR REMODELING 
Christopher Stephen Givens 
A dissertation submitted to the faculty at the University of North Carolina at Chapel Hill in partial 
fulfillment of the requirements for the degree of Doctor of Philosophy in the Department of Cell 
Biology and Physiology in the School of Medicine (Cell and Molecular Physiology) 
Chapel Hill 
2016 
Approved by: 
Ellie Tzima 
Richard Cheney 
Victoria Bautch 
Keith Burridge 
Andrew Dudley 
 
 
ii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
©2016 
Christopher Stephen Givens 
ALL RIGHTS RESERVED  
 
 
iii 
 
ABSTRACT 
 
 
Christopher Stephen Givens: Hemodynamic Mechanisms Regulating Inflammatory Vascular 
Remodeling 
(Under the direction of Ellie Tzima) 
 
  
Hemodynamic forces are critical regulators of vascular health and disease. Shear stress, the 
frictional force of blood flowing over the endothelium, is a major hemodynamic input into vascular 
function. For example, inflammatory blood flow patterns induce programs of intercellular signaling and 
gene expression that cause local vascular inflammation. Endothelial cells mediate the interactions 
between blood flow and blood vessels, and as such are exquisitely sensitive to forces. Platelet 
Endothelial Cell Adhesion Molecule 1 (PECAM-1), a well-known endothelial mechanosensor, is 
required for flow-induced endothelial inflammation, yet the signaling pathways connecting 
hemodynamics, PECAM-1, and vascular inflammation remain to be elucidated. This dissertation 
provides mechanistic insight into two PECAM-1 dependent inflammatory pathways: assembly of 
fibronectin (FN) into fibrils and the role of the adaptor protein Shc in inflammatory vascular 
remodeling.  
FN is an extracellular matrix protein that plays major roles in vascular development and 
disease. Required for embryonic development of the vascular plexus and heart, FN is also heavily 
deposited in atherosclerotic plaques and chronically inflamed vessels. As FN is known to sustain 
endothelial inflammation, knowledge of its assembly is critical to understanding vascular disease. In 
Chapter 2, I demonstrate that FN assembly is controlled by altered hemodynamics via PECAM-1. 
Additionally, I delineate a mechanism by which the small GTPase RhoA and β1 integrins regulate FN 
assembly in a PECAM-1 dependent manner. This is the first time that FN assembly has been 
mechanistically linked to hemodynamics, and suggests a route by which chronic inflammation may 
take hold in the endothelium.  
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Vascular inflammation may result in remodeling of blood vessels, and depending on the 
physical cues at work, this remodeling may result in widening or narrowing of the blood vessels. The 
adaptor protein Shc is a known regulator of endothelial inflammation and outward vascular 
remodeling, and is phosphorylated upon the onset of shear. In Chapter 3, I demonstrate that Shc 
tyrosine phosphorylation is required for outward collateral remodeling in response to femoral artery 
ligation. I also demonstrate that Shc is required for atherogenesis, which is pathological inward 
remodeling of arteries in response to inflammatory flow. Critically, I show the involvement of Shc in 
atherogenesis to be responsive to changes in hemodynamics. These data suggest that Shc is a 
major regulator of vascular remodeling, as well as suggest potential targets for downstream vascular 
therapeutics. 
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Chapter 1 Introduction 
 
ENDOTHELIAL MECHANOSIGNALING: DOES ONE SENSOR FIT ALL? 
Introduction 
 Mechanical forces influence every area of biology, from early development to adult 
physiology and pathology. During development, left-right asymmetry of the growing embryo; pruning 
of the immature vascular plexus; and renal morphogenesis are all regulated by mechanical forces 
(Lucitti et al., 2007; Orr et al., 2006b). Similarly, in the adult organism, several physiological 
processes are dependent on mechanical force sensing, including the senses of touch and hearing as 
well as pulmonary surfactant production resulting from breathing. There is also a dark side to force 
sensing, as tumor metastasis and atherosclerosis are regulated by pathological forces and resultant 
mechanosignaling (Orr et al., 2006b).  
 In the cardiovascular system, forces are critical determinants of vascular homeostasis and 
pathological processes. Vascular smooth muscle cells increase collagen production in response to 
stretch, which contributes to normal collagen synthesis and turnover, but can also lead to the 
development of atherosclerosis (Leung et al., 1976; Rodriguez-Feo et al., 2005). Additionally, 
increases in cardiac load due to exercise or hypertension lead to extensive cardiac remodeling known 
as cardiac hypertrophy (Dorn, 2007). Devastating conditions, such as aortic dissection, are 
fundamentally problems of mechanobiology, and result when wall stress exceeds the strength of 
arterial walls (Humphrey et al., 2015). Also, inflammatory flow patterns, including disturbed and low 
flow conditions, contribute to focal atherosclerotic plaque formation, which is the pathology behind 
debilitating cardiovascular events like stroke and myocardial infarction (Hahn and Schwartz, 2009). 
The past twenty-five years have yielded many insights into the mechanisms behind shear sensing in 
endothelial cells (ECs), including the identification of many putative endothelial shear stress sensors. 
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This review focuses on the shear stress mechanosensors that have been identified in ECs, and 
categorizes them based on their subcellular localization: luminal, junctional, or basal. 
 
Shear Stress and EC Responses 
The vasculature is constantly subjected to two main forces: circumferential stretch and fluid 
shear stress. The force of stretch, which results from the natural pulsatility of blood flow, is normal to 
the vessel wall (Chien, 2007; Tarbell et al., 2014). Stretch can also arise as the result of chronic 
hypertension, causing thickening of arterial walls and decreasing responsiveness to vasodilatory 
stimuli (Lu and Kassab, 2011). Stretch induces specific signaling pathways in the endothelium and 
vascular smooth muscle cells, leading to a complex suite of phenotypes and communication between 
the two cell types (Ando and Yamamoto, 2011; Birukov, 2009; Lu and Kassab, 2011). Fluid shear 
stress is the frictional force felt by ECs as a result of blood flow parallel to the vessel wall (Hahn and 
Schwartz, 2009). Shear stress is represented as a force per unit area; the most common units are 
dynes or Newtons. ECs throughout the vasculature experience a wide range of shear stresses and 
magnitudes (Figure 1.1). Arterial shear stresses range from approximately 10dyn/cm2 in the aorta to 
50dyn/cm2 in smaller arterioles (Papaioannou and Stefanadis, 2005). Shear stress in the venous 
circulation is lower, ranging from 20dyn/cm2 in venules to 1dyn/cm2 in the vena cava (Lipowsky et al., 
1978; Papaioannou and Stefanadis, 2005).   
In vivo, blood flow exhibits differential patterns, which fall into two broad categories: laminar 
and disturbed flow, also known as atheroprotective and atheroprone flow, respectively (Figure 1.2) 
(Hahn and Schwartz, 2009). These flow patterns are determined by vessel geometry, and give rise to 
vastly different gene expression profiles. The difference in flow patterns is sensed by endothelial 
mechanosensors, which transfer differential physical information into divergent biochemical signals. 
Laminar flow is characterized by high, uniform flow, and occurs mostly in straight areas of the 
vasculature, such as the descending aorta (Chatzizisis et al., 2007). ECs in areas of laminar flow 
align in the direction of flow, forming large stress fibers, and exhibit low cellular turnover. Anti-
inflammatory genes are highly expressed, including the transcription factor KLF2 (Chatzizisis et al., 
2007; Parmar et al., 2006). Conversely, disturbed flow is characterized by low and oscillatory flow 
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patterns, and is the main flow regime in areas of the vasculature that are highly curved or bifurcated. 
ECs that experience disturbed flow do not align in the direction of flow and proliferate more rapidly 
(Buchanan et al., 1999; Chatzizisis et al., 2007). Importantly, inflammatory gene expression is 
increased in ECs experiencing disturbed flow. Inflammatory adhesion molecules such as VCAM-1 are 
highly expressed, which can lead to recruitment of monocytes and formation of atherosclerotic 
plaques (Malek et al., 1999). In this manner, areas of disturbed flow are highly correlated with 
atherogenesis. In addition to systemic factors such as smoking or high blood cholesterol, EC 
inflammation caused by disturbed shear stress “primes” the endothelium for atherosclerotic plaque 
growth. A similar mechanism underlies the growth of collateral vessels after stenosis of the nutritive 
artery. Found throughout the body, collateral vessels are connectors between different arterial beds 
(Faber et al., 2014). Collaterals normally do not conduct blood, but upon stenosis of a major artery, 
blood flow markedly increases through the collaterals, increasing the shear stress experienced by 
ECs (Cai and Schaper, 2008; Schaper, 2009; Schaper and Scholz, 2003). This increase in shear 
stress leads to mechanotransduction and activation of signaling pathways that ultimately result in 
transient inflammation of the collateral ECs (Schaper, 2009). Collateral ECs increase their 
proliferation and and promote recruitment of immune cells (Z. Chen et al., 2010; Schaper and Scholz, 
2003; Sweet et al., 2013). These processes guide collateral remodeling, and the collateral vessels 
eventually increase their caliber such that they conduct the amount of blood normally carried by the 
nutritive artery (Schaper, 2009).  
Endothelial responses to flow have been studied extensively in vitro. Early responses include 
K+ and Ca2+ influx, NO production, and ROS production (Hsieh et al., 1998; Nauli et al., 2008; Olesen 
et al., 1988; Yamamoto et al., 2000). Soon thereafter, activation of MAP kinases, eNOS and Akt also 
occur. The discovery that shear stress activates integrins in ECs (Jalali et al., 2001; Tzima et al., 
2002; 2001) opened up a new avenue of research on the importance of the identity of the 
extracellular matrix (ECM) in shear stress signaling (please see Review Forum article by Yurdagul 
and Orr). The current view is that the matrix, and as a result the specific integrins that are binding to 
it, serve as a “check-point” that determines which intracellular signaling responses will be activated 
and which will be inhibited. Examples include the activation of JNK when cells are plated on 
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fibronectin and the activation of p38 MAP kinase when cells are on collagen (Hahn et al., 2011; Liu et 
al., 2008; Orr et al., 2005). Similarly, the activation of p21-activated kinase and the inflammatory 
transcription factor NF-kB is also matrix specific, occurring specifically on fibronectin (Orr et al., 2005; 
2007)  
Another important set of signaling molecules is also regulated by shear stress: members of 
the Rho family of GTPases are highly sensitive to both spatial and temporal regulation by shear 
stress (Tzima, 2006). RhoA is transiently downregulated within 5 minutes of onset of shear stress, 
allowing breakdown and subsequent re-formation of actin stress fibers, while Rac is transiently 
activated starting at 5 minutes and peaking at 30 minutes after onset of shear stress (Tzima et al., 
2002; 2001). Interestingly, activation of Rho family members is subject to integrin control (Tzima, 
2006). Shear stress activates endothelial integrins, which form new connections with the ECM (Tzima 
et al., 2001). This activity activates RhoA, which directs rearrangement of focal adhesions (Collins 
and Tzima, 2013). In unstimulated ECs, the focal adhesion protein vinculin is evenly distributed in 
small puncta throughout the cell. However, after application of shear stress, vinculin aggregates into 
large focal adhesions at the upstream edge of ECs (Girard and Nerem, 1995). Proper spatiotemporal 
activation of both Rho and Rac is required for alignment of ECs in the direction of flow (Tzima et al., 
2002; 2001)as well as establishment of polarity in ECs (Liu et al., 2013). Cdc42 is also activated in 
response to shear (Wojciak-Stothard and Ridley, 2003) and its activation is required for polarization of 
the microtubule organizing center (MTOC) in ECs (Tzima et al., 2003). Furthermore, EC migration 
speed increases when ECs are exposed to shear, an effect mediated by RhoA (Shiu et al., 2004).  
Intermediate responses to shear include transcriptional activation of NF-kB target genes, 
such as ICAM-1 (Orr et al., 2005). In areas of laminar flow, shear signaling cascades culminate with 
downregulation of NF-kB, followed by atheroprotective transcription resulting from ERK5-dependent 
KLF2 expression (Hahn and Schwartz, 2009; Parmar et al., 2006). At this time, ECs also align parallel 
to the direction of flow (Tzima et al., 2001; 2005). In areas of disturbed flow, however, NF-kB and 
other inflammatory signaling is sustained. Long term EC inflammation leads to continuation of ICAM-1 
and VCAM-1 expression, causing recruitment of monocytes to inflamed endothelium, beginning 
atherogenesis (Chatzizisis et al., 2007). Additionally, increased fibronectin deposition occurs in areas 
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of inflamed endothelium, enhancing and sustaining inflammation and atherogenesis in those areas 
(Feaver et al., 2010; Green et al., 2014; Orr et al., 2005). Extensive endothelial protein S-nitrosylation 
also occurs in response to shear stress (Hoffmann et al., 2003). These proteins include heat shock 
proteins, as well as cytoskeletal elements like tropomyosin and vimentin (Huang et al., 2009). The 
diverse suite of shear-induced endothelial signaling and phenotypes implies that ECs possess 
exquisite mechanosensitivity, which is indeed the case. ECs express many putative 
mechanosensors, the major groups of which are discussed below (Figure 1.3).  
 
Apical Mechanosensors 
Primary Cilia Primary cilia are 3-5μm long cellular protrusions provided structure by microtubular 
bundles. Embryonic evidence suggests a requirement for cilia in developing vasculature, where flow 
regimes are low. Developing zebrafish present with cranial hemorrhage after disruption of 
intraflagellar transport protein Ift81, while Pkd2 EC-specific knockout causes hemorrhage in the 
cranium and back of developing mice (Garcia-Gonzalez et al., 2010; Hamik et al., 2007; Kallakuri et 
al., 2015; Parmar et al., 2006; Sen-Banerjee et al., 2005).  
EC primary cilia are primarily found in areas of the vasculature that experience low or 
disturbed flow. Their presence has been demonstrated in chicken embryonic endocardial and venous 
ECs (Van der Heiden et al., 2006). Cilia exist in embryonic mouse aorta and the inner curvature of 
adult mouse aorta, both low flow areas of the vasculature (Nauli et al., 2008; Van der Heiden et al., 
2008). Additionally, zebrafish arteries and veins exhibit cilia (Goetz et al., 2014). The presence of cilia 
is known in primary chicken ECs (Hierck et al., 2008), human umbilical vein ECs (HUVECs) (Iomini et 
al., 2004), and embryonic mouse aortic ECs (Nauli et al., 2008). Laminar shear causes rapid 
disassembly of cilia in ECs, and as such the contribution of cilia to long-term shear stress signaling 
remains unclear (Iomini et al., 2004). 
A body of research investigating cilia-dependent shear responses shows a role for cilia in 
early calcium signaling and nitric oxide (NO) production. To mediate shear-induced calcium and NO 
signaling, primary cilia partner with polycystin 1 and 2 (PKD1 and PKD2, expressed from the Pkd1 
and Pkd2 genes). PKD1, a G-protein coupled receptor (GPCR), constitutively activates Gi/o proteins. 
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Physical association with PKD2, a Ca2+ channel, represses this constitutive activation (Delmas et al., 
2002). Using microfluorimetry, early shear-dependent calcium influx and NO production were 
examined in vitro using aortic ECs from Pkd1null/null mice. Twenty seconds after the application of 
shear, high levels of calcium influx and NO production were observed in wild type cells (Nauli et al., 
2008). However, early calcium influx and NO production were blocked in Pkd1null/null ECs. Additionally, 
Pkd2 is required for shear-induced calcium influx and NO production. These early events are blocked 
by Pkd2 knockdown in ECs (AbouAlaiwi et al., 2009). Interestingly, ECs isolated from an autosomal 
dominant polycystic kidney disease (ADPKD) patient show heterogeneous expression of PKD2. 
PKD2-null ECs from these patients display aberrant localization of eNOS after the application of 
shear stress (AbouAlaiwi et al., 2009).  
 Recent in vivo studies of primary cilia complement previous in vitro studies of cilia. In 
zebrafish embryos, a morpholino against Pkd2 blocks calcium influx in the arterial endothelium 
(Goetz et al., 2014). Tnnt2 and gata1 morpholinos are also used, blocking heartbeat and reducing 
hematocrit, respectively. Tnnt2 morphants display no ciliary deflection, while cilia in gata1 morphants 
only deflect moderately. Importantly, endothelial calcium influx correlates with degree of ciliary 
deflection, as tnnt2 morphants show a severe reduction in EC calcium influx and gata1 morphants 
display only a moderate reduction (Goetz et al., 2014; Nauli et al., 2008).  
 Despite the published work on the involvement of cilia in Ca2+ and NO signaling, the status of 
primary cilia as shear sensors remains unclear. Cilia reside in low flow areas of the vasculature (Y.-S. 
J. Li et al., 2005; Liu et al., 2008; Tzima et al., 2001; Van der Heiden et al., 2008), and are mostly 
absent in areas of high flow. This suggests the intriguing possibility that cilia formation itself is a 
process that depends on blood flow, since cilia form as a response to low or disturbed flow. Although 
this does not exclude the possibility of cilia functioning as mechanosensors, their role as amplifiers of 
shear signals (Cuhlmann et al., 2011; Hierck et al., 2008; Lan et al., 1994) is certainly compatible with 
their presence in areas of low flow. Cilia may act as low flow sensors in the endothelium, but 
disentangling ciliary functions in development and overall EC shear signaling remains a challenge. 
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Glycocalyx The endothelial glycocalyx consists of a mixture of glycoproteins, hyaluronin, and 
proteoglycans such as syndecan-1 and -4. The glycocalyx has a net negative charge due to the 
presence of glycoprotein-bound sialic acid moieties and proteoglycan-bound glycosaminoglycans 
(GAGs). As a result, an extended endothelial surface layer (ESL) is formed as a result of glycocalyx 
interaction with components of blood. The ESL is comprised of plasma proteins, growth factors, and 
cytokines (Chatzizisis et al., 2007; Parmar et al., 2006; Weinbaum et al., 2007). 
Early work on the endothelial glycocalyx revealed a hydrodynamically relevant surface layer 
capable of regulating capillary hematocrit (Desjardins and Duling, 1990; Malek et al., 1999; Pries et 
al., 1997). Using in vivo solute exclusion assays, the height of the glycocalyx was determined to be 
approximately 500nm. High molecular weight dextran was excluded from this 500nm-thick later, and 
the thickness of the layer was reduced by degrading the glycocalyx with an infusion of 
hyaluroninidase (Henry and Duling, 1999; Vink and Duling, 2000; S. Yuan and Z. Sun, 2013). 
Additionally, vascular TNFα infusion reduces glycocalyx height, suggesting that endothelial 
inflammation negatively regulates glycocalyx density (Essner et al., 2005; Henry and Duling, 2000; 
Murcia et al., 2000). Degradation of hyaluronin or inhibition of its synthesis decreases glycocalyx 
thickness in collateral vessels, reducing collateral remodeling after hindlimb ischemia. Shear 
dependent EC proliferation and inflammatory gene expression are also reduced (Grundmann et al., 
2009; Huangfu et al., 2003; Potter et al., 2015). 
The glycocalyx is thought to dampen the force of shear stress that that reaches the EC cell 
surface (Weinbaum et al., 2007). Thus, cells with an intact glycocalyx do not experience appreciable 
shear forces at their plasma membranes. Instead, syndecans link to the cytoskeleton through their 
cytoplasmic termini, providing a possible mechanism for force transfer from shear stress to the 
cytoskeleton (Tkachenko et al., 2005; Van der Heiden et al., 2006; Weinbaum et al., 2003).  Indeed, 
ablation of syndecan function through enzymatic or genetic means leads to blockade of shear stress 
responses in ECs. Degradation of heparin sulfate GAGs, the major GAGs associated with syndecans, 
leads to misregulated actin dynamics in ECs. As a result, ECs do not break down their dense 
peripheral actin band and fail to form new stress fibers after application of shear (Nauli et al., 2008; 
Thi et al., 2004; Van der Heiden et al., 2008; Weinbaum et al., 2007). Syndecan-1 knockout causes 
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misregulation of RhoA and Akt, as well as upregulation of EC inflammatory gene expression after the 
application of shear stress (Goetz et al., 2014; Voyvodic et al., 2014). Correlating with the syndecan-1 
studies, syndecan-4 knockout ECs do not align in the direction of flow and display an increased 
inflammatory phenotype. This leads to a higher atherosclerotic burden in vivo. Importantly, in 
Syndecan-4 KD ECs, VEGFR2 phosphorylation is not altered immediately after application of shear. 
This indicates that syndecan-4 dependent signaling may act independently, or downstream, of 
junctional shear stress signaling (Baeyens et al., 2014; Hierck et al., 2008).  
Enzymatic and genetic studies indicate the importance of glycocalyx components in shear-
related signaling. However, syndecans act as co-receptors for integrins during adhesion, complicating 
the determination of specific function in shear stress signaling (Hassan et al., 2013; Iomini et al., 
2004; McQuade et al., 2006; Stepp et al., 2010; Tkachenko et al., 2005). Many EC responses that are 
misregulated in response to syndecan ablation, including RhoA activation and ICAM-1 and VCAM-1 
exression, are downstream of integrin activation after the application of shear (Liu et al., 2008; Nauli 
et al., 2008; Tzima et al., 2001). Thus, syndecan function in shear signaling may be required for 
integrin function, and not direct shear sensing. Further studies are required to completely disentangle 
specific glycocalyx signaling from integrin-associated signaling in ECs. The glycocalyx as an EC 
mechanosensor remains attractive, but clarity about its function remains elusive.  
 
Heterotrimeric G-proteins and G-protein coupled receptors Heterotrimeric G-proteins participate 
in shear stress signaling and may also form mechanosensitive complexes with known 
mechanosensors. Work done using vesicles loaded with G-proteins and 32P suggests that increasing 
membrane fluidity or applying shear stress leads to GTPase activation (Gudi et al., 1998; Iomini et al., 
2004). The heterotrimeric G-protein Gαq/11 associates with PECAM-1 in unstimulated ECs, rapidly 
dissociating upon application of shear. In vivo, Gαq/11 colocalizes with PECAM-1 in areas of laminar, 
but not disturbed, flow (Delmas et al., 2002; Otte et al., 2009). Interestingly, the association of Gαq/11 
with PECAM-1 is mediated by heparan sulfate, suggesting a link between three candidate 
mechanosensors: PECAM-1, Gαq/11, and the glycocalyx (Murcia et al., 2000; Paz et al., 2014). 
Gαq/11 is also required for activation of Ras by flow, implicating G-proteins in shear-induced MAPK 
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signaling (Gudi et al., 2003; Nauli et al., 2008). Also, siRNA knockdown of Gαq/11 increases the time 
required for calcium influx after the onset of retrograde shear stress (AbouAlaiwi et al., 2009; Melchior 
and Frangos, 2012).  
GPCRs are also implicated as mechanosensitive molecules. The bradykinin B2 receptor 
undergoes a ligand-independent conformational change in response to shear stress or membrane 
fluidizing agents (AbouAlaiwi et al., 2009; Chachisvilis et al., 2006). Furthermore, sphingosine-1 
phosphate receptor 1 (S1P1) is required for signal transduction of many well-characterized shear-
responsive pathways, such as ERK, AKT, and eNOS activation. In this study, small-molecule 
induction of S1P1 proteasomal degradation blocked phosphorylation of ERK and EC alignment after 
application of shear stress. Interestingly, blockage of ERK activation and EC alignment was rescued 
using endocytosis- and ligand binding-deficient mutants of S1P1, indicating that the involvement of 
S1P1 in shear signaling is ligand-independent (B. Jung et al., 2012). Endothelial S1P1 is also required 
for angiogenesis in the mouse retina (Goetz et al., 2014; B. Jung et al., 2012). These studies suggest 
that GPCRs and G-proteins are heavily involved in shear-responsive mechanotransduction and may 
be mechanosensors in their own right.  
 
Ion Channels Hyperpolarization of ECs was one of the first identified EC responses to shear, and is 
among the earliest EC responses to shear (Nakache and Gaub, 1988; Olesen et al., 1988). K+ ion 
channel activity is regulated by shear stress induced deformation of ECs, rather than high flow rate 
over ECs (Ando et al., 1993). After initial hyperpolarization of ECs in response to shear, Ca2+ 
channels open and depolarize the EC (Barakat et al., 1999). Shear-induced Ca2+ influx increases with 
increasing magnitude of shear stress (Yamamoto et al., 2000). Interestingly, the activity of one 
channel, transient receptor potential channel 5 (TRPC5), is enhanced by S-Nitrosylation (Yoshida et 
al., 2006). Though it is not known how shear stress might regulate S-Nitrosylation of TRPC5, the the 
S-Nitrosylation is dependent on eNOS, a shear-responsive protein (Yoshida et al., 2006). 
Several ion channels are putative shear stress sensors in ECs. The endothelial Kir2.1 K+ 
channel has been shown to be mechanosensitive, and when expressed in Xenopus laevis oocytes, 
the oocytes become sensitive to shear (Hoger et al., 2002). Additionally, transient receptor potential 
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vanilloid 4 (TRPV4) has been proposed as a mechanosensor. TRPV4 is sensitive to multiple stimuli, 
including heat, phorbol esters, arachidonic acid, hypotonic shock, and shear stress (Gao et al., 2003; 
Watanabe et al., 2002a; 2003; 2002b). Interestingly, TRPV4 also has demonstrated importance in the 
vasculature, where it regulates vasodilation in carotid arteries, rat mesenteric arteries, and arterioles 
(Earley et al., 2009; Hartmannsgruber et al., 2007; Köhler et al., 2006; Mendoza et al., 2010) 
Regulation of vasodilation by TRPV4 may be achieved through TRPV4-dependent NO production 
from ECs (Cabral and Garvin, 2014). TRPV4 also forms a heterotrimeric, flow-sensitive complex with 
TRPP2 and TRPC1(Du et al., 2014). TRPV4, however, is activated by arachidonic acid, which is 
synthesized by phospholipase A2 (PLA2) in response to shear stress(Pearce et al., 1996). If PLA2 
activity is inhibited, intercellular calcium and vasodilation responses are blocked (Köhler et al., 2006; 
Marrelli et al., 2007). Thus, TRPV4 activation is downstream of enzymatic activity and may not be 
sensitive to the force of flow. However, arachidonic acid synthesis takes place on a slower time scale 
(Pearce et al., 1996) than TRPV4-dependent calcium flux (Du et al., 2014), suggesting that there may 
be a yet undiscovered mechanism behind activation of TRPV4 by shear stress.  
Recent work has identified the mechanically activated cation channels Piezo1 and Piezo2 in 
neurons (Coste et al., 2010). Piezo1 and Piezo2 are implicated in touch sensation in mice and red 
blood cell volume (Cahalan et al., 2015; Ranade et al., 2014b)Transfection into non-mechanically 
activated HEK293T cells confers sensitivity to mechanical stimulation as well as shear stress (Coste 
et al., 2010; 2012; J. Li et al., 2014). HEK293T cells transfected with Piezo1 exhibit increasing 
calcium influx with increasing shear stress. Piezo1 does not share structural features with known 
channels and may represent an entirely new class of mechanically activated ion channel (Coste et al., 
2012). Piezo1 knockout mice are embryonic lethal as a result of major vascular defects manifesting 
as early as E8.5 (Ranade et al., 2014a). The vascular tree fails to prune correctly in both whole-body 
and EC-specific Piezo1 knockouts, and ECs in haploinsufficient arteries do not align in the direction of 
flow (J. Li et al., 2014). Treatment of ECs with Piezo1 siRNA also largely blocks flow-induced EC 
alignment (Ranade et al., 2014a). Though little is known about these channels at the moment, they 
hold tremendous potential for the study of EC shear stress signaling.  
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Caveolae Caveolae are flask-shaped invaginations present in the plasma membrane of various cell 
types. Caveolae are mostly found in cell types that receive mechanical stress, such as fibroblasts, 
adipocytes, and ECs. Caveolae are given their structure by proteins of the caveolin and cavin family 
(CAV1-3 and cavin1-3, respectively) (Echarri and Del Pozo, 2015). Importantly, caveolae rapidly 
disassemble after hypotonic shock, suggesting a role in buffering the cell membrane against 
mechanical stress (Sinha et al., 2011). Caveolae are also important in murine development, as Cav1 
knockout mice display cardiac hypertrophy and thickened coronary vessel walls, along with 
bronchiolar hyperplasia (Murata et al., 2007). 
 Evidence for caveolae in endothelial mechanosensing was first described in rat lungs, where 
increased perfusion of the rat pulmonary vasculature led to enhanced protein tyrosine 
phosphorylation, especially in caveolar compartments (Rizzo et al., 1998b). Additionally, eNOS was 
enriched in rat lung EC caveolae, which served as the main location of eNOS activation after shear 
(Rizzo et al., 1998a). The cholesterol binding antibiotic filipin and cholesterol sequestering compound 
methyl-β-cyclodextrin reduced shear-induced ERK activation in BAECs, suggesting that cholesterol-
rich regions of the plasma membrane are required for shear signaling. However, a limitation of these 
pharmacological treatments is that both caveolae and lipid raft function are disrupted, complicating 
interpretation of results (Park et al., 1998). Transmission electron microscopy images revealed a 
luminal surface increase in caveolae density in ECs subjected to shear stress (Boyd et al., 2003). 
Additionally, shear stress induced Cav-1 translocation to the upstream edge of ECs, where 
hydrostatic pressure is highest on ECs (R. J. Sun et al., 2002). This correlates with the hypothesis 
that caveolae buffer cell membranes against high mechanical stress (Sinha et al., 2011). 
 Genetic evidence for caveolae as mechanosensors has revealed a role for caveolae in 
transduction of shear stress signals but not directly in mechanosensing. In one study, Cav1 knockout 
mice were subjected to partial carotid artery ligation. Whereas WT mice showed a decrease in lumen 
diameter, the Cav1 knockout mice displayed no such change. However, the arterial walls of the Cav1 
knockout carotids did thicken significantly, a result of significant increases in endothelial, medial, and 
adventitial proliferation (Yu et al., 2006). Furthermore, Cav1 knockout carotid arteries were deficient 
in vasodilation as a result of impaired eNOS activation (Yu et al., 2006). In a model of atherosclerosis, 
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Cav1 whole body knockout mice were crossed to ApoE knockout mice, leading to a reduction in aortic 
plaque burden. The reduction in plaque burden caused by Cav1 knockout was accompanied by 
reductions in ICAM-1 and VCAM-1 expression (FernAndez-Hernando et al., 2009). Interestingly, 
reconstitution of only endothelial Cav1 increased the aortic plaque burden and ICAM-1 and VCAM-1 
expression back to control levels, suggesting that caveolin proteins mediate endothelial inflammation 
leading to atherosclerosis. Caveolae have also been linked to the actin cytoskeleton. Knockdown of 
Cav1 increases basal RhoA activity, blocking stress fiber formation in ECs (B. Yang et al., 2011). 
Additionally, Cav1 is required for luminal β1 integrin activation after the onset of shear stress. This 
activation of luminal integrins does not require the actin cytoskeleton. When blocked, luminal β1 
integrin activation reduces shear-induced Src family kinase, Akt, and eNOS signaling in ECs (B. Yang 
and Rizzo, 2013). Whether caveolae are mechanosensors is unclear, and will take more integrative 
research to fully determine. Given that caveolae number increases as a response to shear stress, it is 
likely that they do not act as sensors but are rather shear-regulated, but more research could uncover 
a role for these structures in endothelial force sensing.  
 
Tie Receptors Members of the Tie family of receptor tyrosine kinases have also been implicated in 
shear stress sensing (Chen-Konak et al., 2003; Porat et al., 2004). Tie1, a tyrosine kinase with 
immunoglobulin-like and EGF-like domains 1, is expressed in ECs and its expression maps 
distinctively to regions exposed to disturbed shear stress (Woo et al., 2011). In vitro, its expression is 
downregulated by laminar shear stress, while disturbed flow increases Tie1 promoter activity. 
Deletion of Tie1 increased activation of eNOS and resulted in decreased inflammatory signals in 
response to laminar flow in vitro.  The same group demonstrated a dose-dependent reduction in 
atherosclerosis in Tie1-attenuated ApoE-/- mice, giving credence to the idea that Tie1 is a critical 
regulator of the endothelial response to disturbed shear stress. Although it is mechanoresponsive 
insofar as it alters its expression and modulates downstream signaling, it is unclear if it is a direct 
sensor of shear stress.  
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Junctional Mechanosensors 
PECAM-1 PECAM-1 is an adhesion molecule of the immunoglobulin superfamily. The extracellular 
domain of PECAM-1, which mediates homophilic binding to neighboring ECs, consists of 6 Ig-like 
subunits (Figure 5). The intracellular and extracellular domains of PECAM-1 are linked by a short 
transmembrane domain. The major features of the intracellular domain are 2 ITIM domains. These 
domains contain two tyrosines, 663 and 686, that are phosphorylated rapidly after the onset of shear 
stress. Along with Ca2+ influx and K+ channel activation, PECAM-1 phosphorylation is one of the 
earliest known responses to shear stress. Importantly, it is thought that PECAM-1 phosphorylation is 
independent of calcium influx, as Ca2+ agonists do not increase PECAM-1 phosphorylation on their 
own.  
In vitro studies of the role of PECAM-1 in shear stress signaling are numerous. Early 
evidence implicating PECAM-1 in EC force sensing showed that PECAM-1 phosphorylation, Shp2 
and Gab1 recruitment, and ERK phosphorylation all increase in response to hypo-osmotic shock and 
fluid shear stress (Osawa et al., 2002). Additionally, Shp2 phosphatase activity is required for 
PECAM-1 dependent ERK activation. Using an extracted EC model, Chiu et al identified Fyn as the 
kinase that mediates stretch- and shear stress-induced PECAM-1 phosphorylation (Chiu et al., 2008).  
Later evidence demonstrated that PECAM-1 acts in concert with VE-Cadherin and VEGFR2 to 
mediate a large number of shear stress responses. These responses include EC alignment, NF-kB 
activation, and Akt phosphorylation following application of shear stress (Fleming et al., 2005; Tzima 
et al., 2005). Importantly, PECAM-1 is required for both anti-inflammatory and inflammatory signaling 
in ECs (Tzima et al., 2005). PECAM-1 is required for establishment of polarity in ECs after onset of 
shear stress via spatiotemporal activation of Rac GTPase (Liu et al., 2013). In this model, PECAM-1 
is required for Rac activation downstream of Src and Vav2 phosphorylation, while VE-Cadherin acts 
as a scaffold for localized Rac activation on the downstream edge of ECs. PECAM-1 knockout also 
leads to misregulation of eNOS localization and resultant increased NO production in unstimulated 
ECs (McCormick et al., 2011). Additionally, in PECAM-1 knockout ECs, eNOS activation is decreased 
in response to shear stress (Fleming et al., 2005). 
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 Force application directly on PECAM-1 using ferromagnetic beads has allowed the study of 
specific PECAM-1-dependent signaling pathways (Figure 1.4). Using magnetic beads coated with 
PECAM-1 antibody, early studies demonstrated that direct force on PECAM-1 elicits both PECAM-1 
and ERK phosphorylation (Osawa et al., 2002). PECAM-1 engagement is required for these 
responses, highlighting the importance of confluency in studies of EC shear stress signaling. Further 
studies of direct force application on PECAM-1 have shown that localized force on PECAM-1 can 
activate global cellular stiffening pathways in ECs. Application of force on PECAM-1 using magnetic 
beads manipulates only a small area of the EC; however, after 5 minutes of force, global focal 
adhesion growth and RhoA activation are observed(Collins et al., 2012). The observed focal adhesion 
growth and RhoA signaling culminate in cellular stiffening in response to force application. 
Interestingly, cellular stiffening, related cytoskeletal dynamics, and focal adhesion growth are all 
ECM-specific events. Plating ECs on collagen blocks force-induced focal adhesion growth and 
cytoskeletal dynamics that are normally observed in ECs growing on fibronectin (Collins et al., 2014). 
This suggests that PECAM-1 and integrins act cooperatively in order to mediate downstream 
signaling to force-based events. Since pharmacological inhibition of PI3-Kinase blocks force-induced 
focal adhesion formation and integrin activation (Collins et al., 2012), PECAM-1 may communicate 
with integrins via biochemical means, rather than direct force-transfer through the cytoskeleton. 
PECAM-1 null mice are healthy and fertile (Duncan et al., 1999), which is surprising given the 
role of shear stress signaling in the development of the vascular plexus. However, starting at 4 weeks 
of age, PECAM-1 knockout mice display cardiac defects including increased left ventricle diameter, 
reduced fractional shortening, and reduced ejection fraction (McCormick et al., 2014). Flow-
dependent dilation is blocked in ex vivo arteries from PECAM KO mice due to failure to activate 
eNOS (Bagi et al., 2005).  Additionally, PECAM-1 KO mice subjected to partial carotid artery ligation 
display defects in flow-mediated vascular remodeling and intima-media thickening, due to defects in 
the NF-kB pathway (Z. Chen and Tzima, 2009). PECAM-1 KO mice also show reduced collateral 
remodeling after femoral artery ligation, once again due to reduced NF-kB-dependent transcriptional 
activity (Z. Chen et al., 2010). Results from studies of atherosclerosis using PECAM-1 knockout mice 
have been difficult to interpret, possibly owing to differences in atherogenic genetic background and 
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feeding time. However, across several studies, PECAM-1 knockout mice show reduced 
atherosclerotic plaque formation in the lesser curvature of the aortic arch (Goel et al., 2008; Harrison 
et al., 2013a; Harry et al., 2008; Stevens et al., 2008). This area is constantly exposed to disturbed 
flow, suggesting that PECAM-1 knockout dampens EC inflammatory signaling arising from disturbed 
flow.  
 
VE-Cadherin We have previously shown that PECAM-1, VE-Cadherin and VEGFR2 are sufficient 
and required for shear stress signaling in ECs (Tzima et al., 2005). When VE-Cadherin-expressing 
cells are mixed with VE-Cadherin knockout cells and exposed to flow, the VE-Cadherin expressing 
cells align in the direction of flow, whereas VE-Cadherin knockout cells do not (Tzima et al., 2005). 
Thus, even in the absence of homophilic VE-cadherin adhesion, WT ECs align correctly. This 
suggests that VE-Cadherin acts as an adaptor in shear stress signaling. VE-cadherin knockout 
additionally blocks integrin activation after application of shear stress, but not Src activation (Tzima et 
al., 2005). Src activation is one of the earliest events in shear stress signaling, taking place just after 
PECAM-1 phosphorylation. This suggests that VE-cadherin acts downstream of PECAM-1 in shear 
stress signaling, which allows transactivation of VEGFR2 and induction of downstream signaling 
pathways (Liu et al., 2008; Tzima et al., 2005). The VE-Cadherin transmembrane domain is also 
required for recruitment of VEGFR2 to the mechanosensory complex, further implicating VE-Cadherin 
as an adaptor in this system (Figure 1.5) (Coon et al., 2015).  
Recent evidence suggests that VE-cadherin may also be a mechanosensitive molecule. 
Previous studies suggest that force application on VE-Cadherin using antibody-coated magnetic 
beads does not activate known force-sensitive signaling, however recent evidence shows that this 
phenomenon may be epitope-specific (Barry et al., 2015; Tzima et al., 2005). Application of force to 
VE-Cadherin using the VE-Cadherin FC antibody elicited responses similar to those elicited by force 
on PECAM-1; namely, cell stiffness and actin reorganization (Barry et al., 2015). Additionally, FRET 
studies using PECAM-1 and VE-Cadherin tension sensors suggest that VE-cadherin carries a high-
tension load in unstimulated ECs. This load is reduced once shear stress is applied. Interestingly, 
tension on PECAM-1 is very low before application of shear stress. After the onset of shear, tension 
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increases on PECAM-1 as a result of association with vimentin (Conway et al., 2013). The main role 
of VE-Cadherin in shear stress signaling is likely as an adaptor. However, the recent studies 
mentioned above imply that VE-Cadherin may have other roles in EC shear stress signaling. More 
research is needed to determine whether the force-sensing properties of VE-Cadherin are relevant in 
physiological signaling.  
 
VEGF Receptors VEGF receptors 2 and 3 (VEGFR2 and VEGFR3) are also involved in shear stress 
sensing. VEGFR2, the better characterized of the two, is rapidly phosphorylated at the onset of shear 
(Liu et al., 2008; Shay-Salit et al., 2002; Tzima et al., 2005). Shear stress-induced Akt activation is 
blocked when tyrosines 801 and 1175 of VEGFR2 are mutated, implying that VEGFR2 is required for 
shear-induced PI3 kinase activation and resultant downstream signals (Figure 5). Thus, while there is 
no evidence to suggest VEGFR2 is directly mechanosensitive, its activity is required for intact shear 
stress signaling.  
 Recently, VEGFR3 was shown to be as a constituent of the mechanosensory complex 
containing PECAM-1, VE-Cadherin, and VEGFR2. This evidence also implicates VEGFR3 in sensing 
different magnitudes of shear, adding to our understanding of how different shear patterns are 
sensed. At the onset of shear, VEGFR2 and VEGFR3 are recruited to the mechanosensory complex 
by the transmembrane domain of VE-Cadherin, followed by phosphorylation of both VEGFR2 and 
VEGFR3 (Coon et al., 2015). Evidence also suggests that VEGFR2 and VEGFR3 signal redundantly 
in response to shear stress. Knockdown of both proteins, but not VEGFR2 or VEGFR3 individually, 
blocks shear-induced Akt activation (Coon et al., 2015). Interestingly, VEGFR3 has been implicated in 
determining the sensitivity of different types of ECs to shear stress (Baeyens et al., 2015). Lymphatic 
ECs (HDLECs) and HUVECs, when exposed to a range of shear stress levels, show peak alignment 
at different shear magnitudes. HDLECs align most efficiently around 5 dyn/cm2, while HUVECs align 
most efficiently around 10 dyn/cm2. Additionally, HDLECs express higher levels of VEGFR3 than 
HUVECs do. HDLECs phenocopy HUVECs upon knockdown of VEGFR3, aligning at higher levels of 
shear than normal HDLECs. Taken together, these results suggest that shear stress sensing may be 
more variable across the phenotypic spectrum of ECs than previously thought. Endothelial 
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mechanosensing may not simply be a matter of efficient force transmission and biochemical 
information transfer by one or more specialized EC proteins, the mechanisms of which are uniform 
across ECs. Mechanisms of mechanosensing may vary with endothelial niche bestowed upon them 
by differential expression of mechanosensory constituents. 
 
Basal sensors: Integrins 
 Integrins act as connections between the extracellular matrix and the actin cytoskeleton, 
making them attractive candidate mechanosensors in ECs. However, evidence that integrins are 
direct shear stress sensors in ECs is limited. After application of shear stress or force on PECAM-1, 
integrins are activated globally in ECs (Collins et al., 2012; Tzima et al., 2005; 2001). This global 
activation requires PI3 kinase, suggesting that shear-induced activation of integrins is mediated by a 
biochemical stimulus, such as PIP3, rather force transfer through the cytoskeleton (Collins et al., 
2012; Tzima et al., 2005). Additionally, the amount of force that integrins feel from shear stress is 
1000-5000 times lower than traction forces on integrins (Katsumi et al., 2004). This further suggests 
that integrins are not activated by the direct force of shear stress. However, it has been hypothesized 
that mechanosensitive cells have evolved specialized mechanosensors capable of sensing extremely 
small forces unique to their niche (Orr et al., 2006b). Thus, it is possible that the integrins act as 
specialized endothelial mechanosensors. Integrins are mechanosensitive proteins, and as such, 
could be responding to minute shear stress forces or changes in cytoskeletal tension (Choquet et al., 
1997; Guilluy et al., 2011; Matthews et al., 2006; N. Wang et al., 1993) (For further information about 
the interaction between hemodynamics, integrins, and the ECM, please see Yurdagul and Orr later in 
this issue).  
Integrins serve as the integration site for shear-dependent signaling cascades (Liu et al., 
2008; Tzima et al., 2002; 2001). After the application of shear on ECs, integrins are activated and 
form new connections with the underlying ECM. These new connections with the ECM are required 
for downstream activation of RhoGTPases , and NF-κB (Tzima et al., 2003; 2002; 2001). Integrins 
also influence the endothelial phenotype through integration of upstream signals with signals from the 
ECM. The adaptor protein Shc, which binds with the mechanosensory complex at the onset of shear, 
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binds integrins around 30 minutes after the onset of shear (Jalali et al., 2001; Liu et al., 2008). As a 
result of interaction with two separate mechanosensors, Shc integrates signals of junctional and 
subendothelial origin in both shear and non-shear contexts (Liu et al., 2008; Sweet et al., 2012; 
Sweet and Tzima, 2009) Also, focal adhesion growth resulting from force on PECAM-1 requires 
fibronectin; no growth is observed when cells are plated on collagen (Collins et al., 2014). Collagen 
binding also regulates cytoskeletal dynamics in ECs. When force was applied directly to PECAM-1 in 
ECs grown on collagen, protein kinase A (PKA) was activated, leading to repression of RhoA activity 
and reduction of cell stiffness, while the opposite was true of ECs grown on fibronectin (Collins et al., 
2014). Passive rheology experiments performed on isolated mouse aortas confirmed these 
observations. EC stiffness was high in the aortic arch, where fibronectin density is high, while EC 
stiffness was lower in the descending aorta, where collagen makes up most of the ECM. Interestingly, 
in vivo inhibition of PKA reversed this effect, causing higher EC stiffness in the descending aorta as a 
result of removal of RhoA repression (Collins et al., 2014). Additionally, ECs plated on collagen align 
less effectively than cells plated on fibronectin (Hahn et al., 2011). Other shear-induced signaling 
pathways are also matrix specific. Shear-induced phosphorylation of p21-activated kinase (PAK) 
requires fibronectin connections, while shear-induced phosphorylation of p38 MAP kinase occurs only 
on collagen (Orr et al., 2007; 2005). Furthermore, disturbed flow regimes induce fibronectin 
expression and deposition, which sustains endothelial inflammation through NF-kB-dependent gene 
expression (Feaver et al., 2010). Though integrins likely do not directly sense shear stress, their 
function as integrators of shear stress signaling pathways demonstrates that they are an integral part 
of the EC shear sensing milieu.  
 
Conclusions 
What is a mechanosensor? Do they work alone? 
 A mechanosensor is the primary cellular structure or protein that senses a physical force, 
setting off downstream biochemical signaling pathways. ECs may have one, but their number is likely 
many. PECAM-1, the best studied of the putative EC mechanosensors, is capable of initiating global 
biochemical/signaling cascades in the cell when force is applied on it. A mechanotransducer is a cell 
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structure or protein that is required for conductance of signals generated by force, but not for sensing 
the originating force itself. In ECs under shear stress, integrins likely fall into this category as their 
activation seems to originate from biochemical, and not force-based, signals in ECs. The status of the 
other putative mechanosensors mentioned in this article remains unclear, however. Further 
experiments must be done to eliminate the caveats inherent in the knowledge of each 
mechanosensor. Only then can we definitely assign force-sensing properties to putative EC 
mechanosensors, and begin untangling the signaling relationships they share.  
 An unanswered question is the extent to which the putative mechanosensors work together 
to sense flow and maintain EC mechanosensitivity. There may be only one ultimate mechanosensor 
in ECs, but this seems unlikely given the known cooperation between sensors. Perhaps the best 
example of this is the cooperation between PECAM-1 and integrins, but evidence is starting to 
accumulate that other mechanosensors cooperate as well. For example, it has been shown that 
ligand-independent S1P1 activity is required for maintenance of the glycocalyx, a possible example of 
mechanosensor cooperation as well as a possible mechanism for specific localization of the 
glycocalyx in areas of laminar flow (Zeng et al., 2014). Additionally, the heterotrimeric G-protein 
Gαq/11 complexes with PECAM-1, suggesting that more than one mechanosensor may be working 
together to sense flow (Paz et al., 2014). Interestingly, the Gαq/11 – PECAM-1 interaction is mediated 
by heparin sulfate, a component of the glycocalyx, further suggesting mechanosensor cooperation. 
Lastly, one of the roles of primary cilia is thought to be amplification of signals through the 
cytoskeleton. This could be an instance where cilia act alongside other major mechanosensors to 
help sense the smaller forces from low flow and influence EC phenotype. Related questions center 
around the relationship between shear stress and cyclic stretch. Though some in vitro studies (Zheng 
et al., 2012) suggest that stretch and shear signaling are interrelated processes, little is known about 
any overlap in these two signaling cascades. In order to understand the full scope of vascular 
mechanosignaling, knowledge of the mechanisms of cyclic stretch signaling and shear signaling must 
be incorporated.  
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Developmental questions and endothelial heterogeneity 
 Mice with deleted PECAM-1, Syndecan-1, and Syndecan-4 are healthy and fertile, although 
PECAM-1 knockouts suffer from dilated cardiomyopathy and systolic dysfunction (McCormick et al., 
2014). In knockout mice for other mechanosensory genes, like Pkd1 or Pkd2, defects in development 
haven’t been disentangled from any possible defects in shear stress signaling (Alexander et al., 2000; 
Baeyens et al., 2014; Garcia-Gonzalez et al., 2010). A major issue for the shear stress field moving 
forward is understanding the importance of shear sensing in utero, and the signaling pathways 
involved. Similarly, another challenge for the field is understanding the phenotypes of ECs from 
different vascular beds and how those phenotypes influence shear signaling. Already, we have 
evidence that a shear sensing set point may be regulated by VEGFR3 expression in lymphatic ECs 
(Baeyens et al., 2015). This suggests the tantalizing possibility that specialized vascular beds, like 
lymphatic, brain, or renal ECs may be specialized in their function and methods of shear sensing. 
Perhaps, for different vascular beds, one mechanosensor does not fit all.  
 
Clinical Perspectives 
 Shear stress, and therefore endothelial mechanosignaling, are central to many vascular 
pathologies. Atherogenesis, for example, preferentially occurs in areas of the vasculature that are 
inflamed due to experiencing disturbed flow (Chatzizisis et al., 2007). Furthermore, shear stress may 
influence the rupture of unstable plaques. The fibrous cap of a plaque is exposed to the highest 
strain, and shear stress, at its upstream edge (Gijsen et al., 2008). Previous work has shown that 
macrophage invasion is higher in the upstream edge of plaques (Cicha et al., 2011; Dirksen et al., 
1998), and that resident macrophages in the upstream edge increase expression of proteolytic 
enzymes (Cicha et al., 2011), thereby weakening the plaque. Additionally, the fibrous cap on the 
upstream edge of plaques tends to be more ulcerated and thinner, and when combined with high 
shear stresses may lead to destabilization and rupture of the plaque (de Weert et al., 2009; Gijsen et 
al., 2008). Another common vascular pathology, intimal stiffening, occurs with age. Intimal stiffening is 
associated with increased RhoA activity and vascular permeability, leading to increased leukocyte 
transmigration (Huynh et al., 2011). Additionally, conditions that affect vasodilation, such as aging 
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and hypertension, modify the hemodynamic environment. In tests of femoral artery shear rates in old 
and young men, old men showed lower shear rates (Trinity et al., 2014), predisposing the older men 
to endothelial inflammation. Flow patterns are also altered in older men: anterograde flow is reduced, 
while retrograde flow is increased. These changes combine to increase the overall oscillatory nature 
of blood flow in the femoral artery, once again predisposing older men to increased endothelial 
inflammation (Young et al., 2010). While exercise transiently reduces age-related increases in 
oscillatory shear index (Padilla et al., 2011), much work remains before the full involvement of 
endothelial mechanosignaling in a range of vascular pathologies can be determined.  
 
Future directions 
 How should new mechanosensors be discovered? How should putative mechanosensors be 
validated? There are many in vitro and in vivo models for determining function of cellular structures or 
proteins in shear sensing (for more in depth information on these models, please see Bowden, et al, 
later in this issue). Moving forward, every effort should be made to mix reductionist and integrative 
approaches as much as possible (Figure 1.6). For example, magnetic bead pulling experiments are 
an excellent way to assign force-sensing function to a protein. However, these experiments do little to 
illuminate how that protein may behave in the context of a monolayer or an adult animal. Likewise, 
simply studying mouse knockouts or in vitro models of shear makes assignment of direct force-
sending function problematic. By mixing reductionist and integrative approaches, we can better 
understand known putative mechanosensors and more easily find new candidate mechanosensors. 
When the mechanosensory infrastructure of ECs is more fully understood, a more full knowledge of 
intracellular signaling pathways will follow. By studying these pathways using a mixture of in vitro and 
in vivo approaches, the aim is that one or more signaling pathways that regulate inflammatory, but not 
atheroprotective, signaling are identified. Discovery of such a pathway could allow rational design of 
treatments that block endothelial inflammation, and thus development of atherosclerosis and other 
shear-induced vascular pathologies. This could lead to novel therapeutics of enormous potential.  
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STIFFNESS AND VASCULAR PHENOTYPES 
Introduction 
 Mechanical forces are potent biological stimuli, especially in the vasculature where forces act 
as critical determinants of vascular physiology and pathology (Hahn and Schwartz, 2009; Orr et al., 
2006b).  Vascular pruning and tone are regulated by hemodynamics, and pathologies like 
atherosclerosis are potentiated by inflammatory blood flow patterns (Chatzizisis et al., 2007; Davies, 
1995; Hahn and Schwartz, 2009; Lucitti et al., 2007; Orr et al., 2006b). The endothelium acts as a 
major mechanosensor in the vasculature, receiving major mechanical input from shear stress, the 
force exerted on the endothelium by blood flow. ECs also experience mechanical input in the form of 
stiffness, which manifests in two ways: vascular stiffness and endothelial stiffness. Vascular stiffness 
increases as a result of age and other factors(Kohn et al., 2015a) and causes upregulation of RhoA 
signaling(Huynh et al., 2011). Conversely, endothelial stiffness requires RhoA signaling, and 
increases as a result of direct force applied to endothelial mechanosensors (Collins et al., 2014; 
2012). Importantly, along with its involvement in stiffness-related signaling, the RhoA pathway is 
regulated by shear stress(Tzima et al., 2001) Though substrate stiffness, endothelial stiffness, and 
hemodynamics may be interrelated processes, the exact mechanisms underlying these processes 
remain little understood. This review will focus on the common mechanisms shared between shear 
stress, vascular stiffness, and endothelial stiffness, in an attempt to define what is known and what 
must be determined about the interrelation of these mechanical pathways in the vasculature.  
 
Shear stress is a critical determinant of endothelial phenotype 
 As a result of their luminal position, ECs are constantly subjected to fluid shear stress, the 
frictional force felt by ECs as a result of blood flow parallel to the vessel wall (Hahn and Schwartz, 
2009). Depending largely on vessel geometry, blood flow patterns fall into two broad categories: 
laminar and disturbed flow. Laminar flow, also known as atheroprotective flow, is characterized by 
high, unidirectional flow, and occurs mostly in straight areas of the vasculature (Chatzizisis et al., 
2007). Laminar flow induces a unique endothelial phenotype, where ECs form large stress fibers, 
align in the direction of flow, express anti-inflammatory genes such as KLF2, and exhibit low turnover 
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(Chatzizisis et al., 2007; Parmar et al., 2006). Areas of disturbed flow, also known as atheroprone 
flow, exhibit low and oscillatory flow patterns, and mainly occur in areas of the vasculature that are 
highly curved or bifurcated. ECs that experience disturbed flow do not align in the direction of flow, 
exhibit increased proliferation, and increase their expression of inflammatory adhesion molecules like 
ICAM-1 and VCAM-1 (Buchanan et al., 1999; Chatzizisis et al., 2007; Malek et al., 1999). Increased 
inflammation “primes” the endothelium for atherosclerotic plaque growth, and when combined with 
pathologic systemic factors, like smoking of high cholesterol, induce focal plaque growth in areas of 
disturbed flow.  
 In order to sense and respond to flow, ECs express numerous mechanosensory proteins, 
including a junctional mechanosensory complex comprised of PECAM-1, VE-Cadherin, and VEGFR2 
(Tzima et al., 2005). PECAM-1 is required for many shear-induced endothelial processes. In vivo 
manipulation of shear stress by partial carotid artery ligation uncovered a requirement for PECAM-1 
in vascular remodeling (Z. Chen and Tzima, 2009). In PECAM-1 knockout mice, ECs in partially 
ligated carotid arteries are unable to activate NF-kB, blocking ICAM-1 and VCAM-1 expression and 
consequent recruitment of leukocytes. Similar results are observed after femoral artery ligation, where 
collateral vessel remodeling is reduced in PECAM-1 knockout mice as a result of blunted endothelial 
inflammation (Z. Chen et al., 2010). In vitro studies confirm that PECAM-1 is required for endothelial 
inflammatory signaling, as well as ERK and Akt activation (Osawa et al., 2002; Tzima et al., 2005). In 
addition to its role in regulation of shear-induced endothelial inflammation and kinase activation, 
PECAM-1 is an important regulator of the actin cytoskeleton in response to shear. Studies have 
shown that PECAM-1 is required for shear-induced endothelial alignment, as well as force-induced 
integrin activation downstream of PI3K (Tzima et al., 2005). Furthermore, PECAM-1 is required for 
Rac1 activation, which leads to the establishment of polarity after the induction of shear stress (Liu et 
al., 2013). 
 
Rho GTPases regulate cytoskeletal dynamics and mechanics 
 A major subset of endothelial responses to shear is based in regulation of the actin 
cytoskeleton. These include alignment in the direction of flow, stress fiber formation, focal adhesion 
 
 
24 
maturation, and increased endothelial contractility. The Rho family of GTPases, including RhoA, 
Rac1, and Cdc42, work together dynamically to regulate these processes (Nobes and Hall, 1995; 
Tzima, 2006; Wojciak-Stothard and Ridley, 2003). These proteins are differentially regulated in 
response to shear and other stimuli (Tzima et al., 2002; 2001; Wojciak-Stothard and Ridley, 2003; 
Yamaguchi et al., 2001). Additionally, RhoA and Rac1 actively repress one another, adding to the 
complex interplay between this family of GTPases (Nimnual et al., 2003; Rottner et al., 1999; 
Yamaguchi et al., 2001).  
 Alignment in the direction of flow is a hallmark of endothelial shear stress responses(Tzima et 
al., 2005; 2001). Essentially a process of polarity determination followed by stress fiber formation, 
alignment relies on dynamic regulation of Rac1 and RhoA (Liu et al., 2013; Tzima et al., 2002; 2001). 
At the onset of flow, Rac1 is activated at the downstream edge of ECs, while RhoA is transiently 
downregulated (Wojciak-Stothard and Ridley, 2003). This allows for the simultaneous creation of a 
polarity complex and destruction of stress fibers. If downregulation of RhoA does not occur at this 
step, stress fibers are not abolished and ECs do not align in the direction of flow (Tzima et al., 2001). 
After polarity is established, Rac1 is downregulated simultaneous with an upregulation of RhoA 
activity, as stress fibers are formed (Tzima et al., 2002; 2001).  
 Endothelial contractility is derived from RhoA-regulated myosin contractility. Contractility has 
implications for barrier formation, immune cell transmigration, and migration of ECs (Dudek and 
Garcia, 2001; Lessey-Morillon et al., 2014; Shiu et al., 2004). The main source of contractility in ECs 
is activation of myosin light chain (MLC) through phosphorylation (Dudek and Garcia, 2001). The 
phosphorylation state of MLC is a delicate balance, and is maintained through oppositional MLC 
kinase (MLCK) and MLC phosphatase (PP1) activity (Kimura et al., 1996; Tinsley et al., 2000). While 
MLCK is regulated through cytokine-dependent Ca2+/Calmodulin mechanisms (Dudek and Garcia, 
2001), PP1 activity is regulated by RhoA-Rho associated kinase (ROCK) signaling pathways (Amano 
et al., 1997; Essler et al., 1998; Kimura et al., 1996). When ECs are activated with thrombin, cell 
contractility increases dramatically (Essler et al., 1998). This effect is negated by inhibition of RhoA or 
cellular injection of PP1, indicating that RhoA-dependent inhibition of PP1 is necessary for an 
increase in cellular contraction. Regulation of cellular tension is also critical for focal adhesion 
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maturation. While Rac1 and Cdc42 are required for the initial formation of focal complexes, RhoA, 
through ROCK-MLC-dependent contractility, causes focal adhesion maturation through an increase in 
tensional forces on the focal complexes (Rottner et al., 1999; Wolfenson et al., 2013).  
 Integrins also play a central role in many cellular mechanical processes. Critically, shear-
dependent RhoA and Rac1 activation require new integrin ligations (Tzima et al., 2002; 2001). When 
new integrin ligation is blocked, ECs cannot polarize and do not align in the direction of flow. Traction 
forces are also generated by integrin-based focal adhesions (S. Li et al., 2005). These centripetal 
forces are required for cell motility, and increase in response to shear stress (Shiu et al., 2004). 
Traction forces are also generated by cell adhesion. Over the course of endothelial adhesion, traction 
forces are the highest early in the spreading process, before being confined mostly to the edges of 
cells later in adhesion (Reinhart-King et al., 2005). Traction forces also increase with ligand density 
during the spreading process, further implicating integrins in force generation and substrate sensing.  
 
Vessel stiffness regulates endothelial contractility 
 Vessel stiffness is strongly correlated with age (Benetos et al., 2002; Huveneers et al., 2015; 
Kohn et al., 2015a; Lakatta, 2003). Vessels derive their mechanical characteristics from elastin and 
collagen (CL), the two main matrix proteins in vessel walls (Burton, 1954). The ratio of elastin to CL in 
the vessel wall is regulated by balancing matrix protein and matrix metalloproteinase expression 
(Kohn et al., 2015a). Elastin is more distensible than CL, while CL confers the majority of stiffness to 
blood vessel walls (Burton, 1954). Young vessels exhibit a higher elastin to CL ratio, and as such are 
more compliant than older vessels, which express a lower elastin to CL ratio (Burton, 1954; 
Schlatmann and Becker, 1977). As vessels age, the elastin to CL ratio is changed through the 
fragmentation of elastin fibers and gradual accumulation of CL. During this process, CL both replaces 
smooth muscle cells (SMCs) and contributes to intima-media thickening (Lakatta, 2003; Schlatmann 
and Becker, 1977). Thus, when an organism ages, its vessels progressively stiffen over time due to 
natural processes. Increased vessel stiffness also strongly correlates with adverse cardiovascular 
events, like atherosclerosis, hypertension, and heart failure (Benetos et al., 2002; Kohn et al., 2015a). 
Understanding vessel stiffness is necessary for designing therapeutics for vascular diseases. In 
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particular, understanding the mechanisms by which vessel stiffness regulates endothelial phenotype 
is critical for integrating the fields of shear stress and extracellular matrix biology, which comprise the 
two major mechanical inputs that regulate endothelial phenotype.  
 When taken together, studies into the effects of substrate stiffness on endothelial phenotype 
begin to tell a cohesive story of increased endothelial contractility and sensitization to stimuli. Early 
work from Peng et al demonstrated the effects of differing substrate stiffness on shear-induced eNOS 
phosphorylation(Peng et al., 2003). ECs were coated on silastic tubing of differing stiffness, followed 
by pulse perfusion with culture media. eNOS phosphorylation increased 2.5-fold in ECs from the 
softer tubes, while eNOS phosphorylation was blocked in ECs cultured on stiff tubes. These results 
suggest that stiffness may counteract the effects of laminar flow on ECs, conditions normally 
conducive for eNOS activation. Additional studies suggest that increasing substratum stiffness 
sensitizes ECs to cytokine treatment. After treatment with LPS, ICAM-1 and VCAM-1 expression was 
higher in ECs plated on a 40 kPa substratum than in ECs plated on a 1.5 kPa substratum, suggesting 
an intersection between increased stiffness and inflammatory signaling in ECs (Mambetsariev et al., 
2014). Also, when ECs are plated on 11 kPa and 1.2 kPa substrata, the difference in stiffness leads 
to a difference in cellular responses to thrombin treatment. The ECs plated on stiffer substratum 
exhibit higher permeability and ERM phosphorylation after thrombin treatment, both suggestive of 
increased RhoA activity as a result of stiffer substrate (Krishnan et al., 2011). In addition, ECs grown 
on stiff substrates and treated with LPS show a significant increase in GEF-H1 expression when 
compared to cells grown on soft substrates (Mambetsariev et al., 2014). Since GEF-H1 is an activator 
of RhoA, this suggests that ECs grown on stiff substrates possess an intrinsically greater capacity for 
RhoA activation than ECs grown on soft substrates.   
 Increased RhoA-dependent contractility is a hallmark of ECs growing on stiffer substrates. 
ECs cultured on stiffer substrates exhibit increased junctional width and permeability to FITC-
dextran(Huynh et al., 2011). Interestingly, permeability and junction width were normalized by 
inhibition of ROCK, implicating RhoA signaling (Huynh et al., 2011). Further in vitro experiments show 
that substrate stiffness influences endothelial responses to shear stress. Compared to soft 
substrates, stiffer substrates induce higher shear-dependent RhoA activation (Kohn et al., 2015b). 
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ERK and eNOS signaling are also reduced on stiffer substrates, suggesting that stiffness may induce 
endothelial dysfunction through mechanisms outside of RhoA activation. In vivo, atomic force 
microscopy (AFM) measurements showed that the aortas of aged mice were found to be stiffer than 
aortas from young mice. This age-dependent increase in stiffness lead to an increase in permeability 
to Evans blue dye and junction width in the aortic endothelium of older mice, both of which were 
normalized by ROCK inhibition (Huynh et al., 2011). Several other studies also demonstrate barrier 
integrity decreases induced by stiffness. Kohn et al showed that while shear stress normalizes barrier 
integrity on stiff substrates, junction width remains increased(Kohn et al., 2015b). Also, ECs plated on 
stiff substrates exert increased baseline traction forces, which can be normalized by ROCK inhibition 
(Huynh et al., 2011; Krishnan et al., 2011). This further supports the idea that RhoA-dependent 
contractility increases with substrate stiffness.  
 Arterial stiffness positively correlates with cardiovascular risk (Mitchell et al., 2010). While the 
mechanistic details of stiffness-induced pathologies are little understood, the relation of stiffness to 
the progression of atherosclerosis is becoming clearer. Interestingly, blood vessels in ApoE-/- mice 
are stiffer as a result of increased CL and fibronectin (FN) expression and deposition (Kothapalli et 
al., 2012).  The observed increase in VSMC expression of FN and CL is reduced by treatment with 
either HDL or ApoE3, two factors that are known to be anti-atherogenic. ApoE3 treatment also 
reduces RhoA activation and cellular stiffness in VSMCs (Hsu et al., 2015). Importantly, when ApoE-/- 
mice are treated with BAPN, an inhibitor of CL crosslinking, aortic stiffness is reduced. Additionally, 
chronic treatment with BAPN reduces atherosclerotic burden in ApoE-/- aortas, providing mechanistic 
evidence that vessel stiffness plays an important role in the development of atherosclerosis. 
Increased substrate stiffness also increases immune cell accumulation in vivo and in vitro (Huynh et 
al., 2011; Kothapalli et al., 2012). Furthermore, shear stress is also known to regulate ECM 
expression by ECs. Oscillatory flow patterns have been shown to induce FN expression in ECs in a 
PECAM-1 dependent manner. The increase in FN expression leads to sustenance of endothelial 
inflammation, stimulating atherosclerotic development (Feaver et al., 2010; Gelfand et al., 2011). 
What is not known, but is tantalizing to speculate about, is whether increased FN deposition in areas 
of the vasculature that experience oscillatory flow translates into a focal increase in stiffness. Such a 
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focal increase in stiffness would provide a second atherogenic input into local plaque formation, but it 
is unknown whether this is the case. The mechanisms by which arterial stiffness regulates the 
development of atherosclerosis are just beginning to be understood. When combined with our 
knowledge of endothelial shear stress signaling, a greater understanding of stiffness signaling 
mechanisms will help create a fully integrated picture of endothelial mechanosensing. Additionally, 
such a full understanding will help open new avenues for vascular therapeutics.  
  
Direct force on ECs induces cellular stiffening 
 While vessel stiffness derives from increased amounts of ECM proteins deposited into the 
vessel wall in response to age, hemodynamics, and other stimuli, endothelial stiffness derives from 
contractility of the actin cytoskeleton in response to force. The stiffness in ECs is RhoA-dependent, 
and selectively occurs based on the type of ECM the ECs are growing on. At this early stage, the 
relationship between endothelial stiffness and shear stress is unclear, but recent data suggest that 
atheroprotective flow may lead to more compliant ECs, while atheroprone flow may induce a stiffer 
phenotype.  
Recently, the effects of force applied directly on the endothelial mechanosensor PECAM-1 
have been determined(Collins et al., 2014; 2012; Tzima et al., 2005). Force is directly applied to ECs 
using either permanent magnets or a magnetic tweezers system (Tim O'Brien et al., 2008). Combined 
use of these systems allows sustained and pulsatile force application, respectively. By pulling 
specifically on PECAM-1 using magnetic beads, Collins et al determined that pulsatile force on 
PECAM-1 induced an increase in cellular stiffness on the order of minutes (Collins et al., 2012). The 
observed increase in stiffness occurred downstream of integrin activation, where RhoA was activated 
by GEF-H1 and LARG. This activation of RhoA resulted in both adaptive stiffening and focal adhesion 
formation. Importantly, the observed integrin ligation, RhoA activation, and downstream cytoskeletal 
stiffening all occurred on a global scale in force-stimulated ECs. Global activation of these pathways 
occurred even though force on PECAM-1 is delivered to only one small area of each stimulated cell. 
This, along with the timescale of the stiffening response, suggests a biochemical method of signal 
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transduction, as opposed to direct mechanotransduction through cytoskeletal elements (Ingber, 1993; 
Na et al., 2008).  
 In another study from our group, Collins et al determined that endothelial stiffening is not a 
universal phenomenon; ECs selectively stiffened based on the composition of the underlying ECM 
(Collins et al., 2014). When force was applied directly to ECs growing on FN, cellular stiffening and 
focal adhesion growth occurred. However, if ECs were grown on CL, force-dependent stiffening and 
focal adhesion growth did not occur, suggesting differential activation of RhoA. Indeed, reduced 
force-dependent activation of RhoA occurred on ECs cultured on CL. This was a result of inhibitory 
phosphorylation of RhoA by PKA (Collins et al., 2014). Notably, when ECs grown on CL were treated 
with a PKA inhibitor, they phenocopied ECs grown on FN by increasing stiffness, stress fiber 
formation, and focal adhesion formation in response to force. Since hemodynamics are known to 
regulate ECM compotision (Feaver et al., 2010), ex vivo passive microbead rheology (Hoffman et al., 
2006) was used to determine whether local differences in ECM composition affected the the stiffness 
of aortic ECs. The stiffness of ECs in the aortic arch, an area that experiences disturbed flow, and the 
descending aorta, which experiences laminar flow, was assayed. Interestingly, ECs in the aortic arch 
were stiffer than ECs in the descending aorta. These results correlated with the known high levels of 
FN in the aortic arch and high levels of CL in the descending aorta, respectively, and suggest that 
hemodynamics may play a direct and indirect role in endothelial stiffening. Notably, when the mice 
were treated with a PKA inhibitor, aortic ECs in the descending aorta once again phenocopied ECs in 
the aortic arch, stiffening in spite of the high proportion of CL in the ECM.  
The physiological significance of endothelial stiffening remains unknown. It has been shown 
that neutrophil adherence on TNFα treated ECs increases endothelial stiffness and F-actin content 
(Q. Wang et al., 2001; Q. Wang and Doerschuk, 2000). Additionally, using magnetic tweezers, force 
applied directly to ICAM-1 induces a rapid stiffening of ECs. Notably, endothelial stiffening 
downstream of force on ICAM-1 is much more rapid than stiffening downstream of PECAM-1. Also, 
stiffening downstream of ICAM-1 is not ECM-selective, suggesting that integrin ligation is not required 
for this process (Lessey-Morillon et al., 2014).  
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Conclusion 
The interplay between hemodynamics, vessel stiffness, and endothelial stiffness is a new and 
exciting avenue of study. While early work shows promise, many aspects of the relationship between 
hemodynamics and stiffness remain unclear. For example, endothelial contractility and stiffening are 
both RhoA dependent processes. However, whether these two processes are separate, or are two 
measures of the same phenotype, is unknown. Additionally, it is tantalizing to speculate about a link 
between atherogenic flow patterns and focal vessel stiffness. Does increased FN deposition in areas 
of the vasculature that experience oscillatory flow translate into a focal increase in arterial stiffness? 
Along with oscillatory flow, such a focal increase would provide a second atherogenic input into local 
plaque formation, but it is unknown whether this is the case. The mechanisms by which arterial 
stiffness regulates the development of atherosclerosis are just beginning to be understood.  
Additionally, the physiological significance of endothelial stiffness remains unknown. Taken 
together, the studies of neutrophil-induced stiffening suggest that ECs stiffen in response to immune 
cell binding, possibly to aid transmigration. Additionally, the studies conducted by applying force on 
PECAM-1 suggest the possibility that hemodynamics may also influence endothelial stiffness in vivo. 
Importantly, this focal stiffness could be neutrophil-independent, yet still aid transmigration, therefore 
enhancing atherosclerotic plaque formation. Perhaps this focal stiffness could aid the cessation of 
leukocyte rolling along the endothelium, which must occur before transmigration. However, further 
study is required to delineate the signaling relationships that underlie endothelial stiffening, as well as 
the full physiological significance of endothelial stiffness.  
When combined with our knowledge of endothelial shear stress signaling, a greater 
understanding of stiffness signaling mechanisms will help create a more fully integrated picture of 
endothelial mechanosensing. Such a picture may present novel mechanisms underlying the 
progression of atherosclerosis. An integrative knowledge of new mechanisms and how they work 
together will open up new avenues for vascular therapeutics. 
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BIOLOGY OF THE ADAPTOR PROTEIN SHC 
The Src homology 2 containing transferring protein (Shc) proteins are a family of adaptor proteins that 
are specialized for mediating receptor tyrosine kinase (RTK) and other phosphotyrosine signaling. 
Perhaps the best known member of the family, ShcA (hereafter referred to as Shc), consists of three 
ubiquitously expressed isoforms: p46, p52, and p66(Ravichandran, 2001; Wills and Jones, 2012). 
These three isoforms are all structurally similar, sharing a common layout of three domains: an 
amino-terminal phosphotyrosine binding (PTB) domain, a carboxy-terminal Src homology 2 (SH2) 
domain, and a Collagen homology 1 (CH1) domain which connects the two(Wills and Jones, 
2012)(Figure 1.7). Additionally, the three isoforms’ difference in size owes to an amino-terminal 
Collagen homology 2 (CH2) domain, which is longest in p66Shc and absent in p46Shc. Shc is a 
multifunctional protein whose variety of functions arises from combinatorial functions of each 
individual domain, resulting in profound consequences for cell signaling and development(Hardy et 
al., 2007). The PTB domain is known to mediate epidermal growth factor receptor (EGFR) signaling 
through binding to autophosphorylation sites on the intracellular domain of EGFR(Sakaguchi et al., 
1998). Furthermore, PTB domain interaction with phospholipids and phosphatidylinositol 3-kinase 
(PI3K) is required for Shc signaling in response to insulin, but not epidermal growth factor (EGF) or 
platelet derived growth factor (PDGF)(Ugi et al., 2002). The SH2 domain also mediates signaling 
pathways, interacting with T-cell receptor (TCR) in response to TCR and CD4 
stimulation(Ravichandran et al., 1993). The SH2 domain additionally interacts with PDGF receptor 
(PDGFR) at intracellular autophosphorylation sites in response to PDGF treatment(Yokote et al., 
1994). In mice, the SH2 domain is required for nerve and skeletal muscle development(Hardy et al., 
2007). Expressing Shc with a nonfunctional SH2 domain causes disruption of nerve growth; when 
expressing the mutant SH2 protein in skeletal muscle, the mice develop but have poor motor function 
resulting from reduced spindle and intrafusal fiber generation(Hardy et al., 2007). 
 The CH1 domain of Shc contains three tyrosines that are subject to phosphorylation by RTKs 
and Src family kinases: Tyr239/240 and Tyr317. These tyrosines are phosphorylated in response to 
cellular stimulation by EGF, PDGF, and insulin(Ravichandran et al., 1993; Sakaguchi et al., 1998; Ugi 
et al., 2002; Yokote et al., 1994). In addition to regulating the conformation of Shc, phosphorylation of 
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these tyrosines mediates interaction with downstream signaling partners, notably the adaptor protein 
Grb2(R. George et al., 2008; Suenaga et al., 2004; Wills and Jones, 2012). Association with Grb2 is a 
well-understood pathway, in which Tyr230/240 and Try317 of the CH1 domain are phosphorylated, 
which leads to recruitment of Grb2. The association of Shc with Grb2 increases the affinity of Grb2 for 
SOS, a Ras-activating GTPase that activates Ras after association with Grb2(Ravichandran et al., 
1995; Salcini et al., 1994; Walk et al., 1998).  
 Shc is also a major player in cardiovascular biology. The ShcA knockout mouse is embryonic 
lethal due to massive cardiovascular defects(K. M. Lai and Pawson, 2000). These include cardiac 
defects, such as poor trabeculation and cardiac cushion formation, and angiogenic defects that lead 
to a less complex, dilated vascular phenotype(K. M. Lai and Pawson, 2000). Interestingly, fibroblasts 
from these mice are hypercontractile and do not spread in culture, suggesting inappropriate activation 
of RhoA. The PTB domain also plays a specific role in cardiac development, as impaired 
trabeculation occurs in embryonic mice expressing a nonfunctional PTB domain(Hardy et al., 2007). 
Shc also regulates endothelial responses to shear stress. After application of shear, Shc associates 
with VE-Cadherin and VEGFR2, where it is phosphorylated. This phosphorylation is dependent on 
Src and VEGFR2 tyrosine kinase activity(Liu et al., 2008). Additionally, Shc is required for shear-
dependent NF-κB nuclear localization, attendant inflammatory gene expression, and ERK 
activation(Liu et al., 2008). A similar phenotype was seen in an endothelial-specific Shc knockout 
mouse, when collateral arteries show impaired remodeling after femoral artery ligation(Sweet et al., 
2013). The lack of remodeling is due to impaired endothelial inflammatory signaling, Notch activation, 
and arterial specification(Sweet et al., 2013).These findings establish Shc as a critical player in 
endothelial mechanosignaling. 
 
BIOLOGY OF FIBRONECTIN, A CRITICAL EXTRACELLULAR MATRIX PROTEIN 
Fibronectin (FN) is a major constituent of the ECM, where it is actively assembled into fibrils that abet 
cellular adhesion in a variety of tissues(Schwarzbauer and DeSimone, 2011). In pre-chordate 
species, some homologs of FN domains have been found, but no protein homologous to FN itself 
exists(Hynes, 2012). Thus, it is thought that FN arose along with the blood vasculature, a hypothesis 
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supported by the critical importance of FN in vascular development and function(Astrof and Hynes, 
2009; Hynes and Zhao, 2000). Developmental studies of genetically ablated FN in mice show a wide 
variety of vascular defects, including thickened cardiac walls, lack of cardiac jelly, and poor red blood 
cell development(E. L. George et al., 1993). Furthermore, while FN null embryos display normal 
specification of primitive heart cells, heart morphology in FN null embryos is abnormal, suggesting a 
role for FN in mechanical processes, even early in development(E. L. George et al., 1997). 
Additionally, when FN was ablated in cardiac progenitor cells, the resulting embryos displayed 
malformed aortas and septal defects between the ventricles of the heart(D. Chen et al., 2015) 
 FN achieves a broad diversity of function through the use of many functional domains. FN is 
composed of three types of domains: FNI, FNII, and FNIII domains (Figure 1.8). FNI and FNII 
domains are highly ordered, containing disulfide bonds to give the protein three-dimensional 
structure(Schwarzbauer and DeSimone, 2011). Conversely, FNIII domains consist of 7-stranded β-
barrels and no disulfide bonds, allowing the conformational changes necessary to achieve 
fibrillogenesis(Schwarzbauer and DeSimone, 2011). The domains of FN associate with one another 
in various combinations, producing higher order structures like detergent-insoluble fibrils. One major 
assembly domain is a 70 kDa stretch of FN, including FNI1-5, which mediates FN-FN 
binding(Schwarzbauer and DeSimone, 2011). Other domains, such as FNIII1-2, are also required for 
FN assembly, though denaturation or other structural breakdown is required to uncover this cryptic 
site and increase binding to I1-5(Hocking et al., 1994; Sechler et al., 2001). The Arg-Gly-Asp (RGD) 
amino acid sequence, which is present in III10, is required for integrin α5β1binding to FN, and without 
this domain, efficient fibrillogenesis does not occur(Sechler et al., 1997; Singh et al., 2010). Mutation 
of the RGD sequence to a nonfunctional Arg-Gly-Glu (RGE) sequence induces a shortened anterior-
posterior axis in embros, as well as increased apoptosis at E9.5(Takahashi et al., 2007). In 
agreement with these data, genetic ablation of α5 integrin produces cardiovascular defects, such as 
abnormal vessel formation and primitive blood cell leakage at E9.5(J. T. Yang et al., 1993). The HepII 
domain (FNIII12-14) also participates in adhesion by acting as a co-receptor for Syndecans, where 
Syndecan-2 is notably required for FN assembly in transformed fibroblasts(Galante and 
Schwarzbauer, 2007; Singh et al., 2010).  
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 Alternative splicing is also an important facet of FN function. Alternative spliceforms of FN 
may contain Extra Domain A (EDA), Extra Domain B (EDB), or a part of the Variable (V) region, 
which can be 0, 64, 89, 95, or 120 amino acids long in humans (V0-V120, 
respectively)(Schwarzbauer and DeSimone, 2011). The diversity of spliceforms imparts further variety 
of function on FN. The EDA and EDB regions, for example, are absent in plasma FN but present in 
cellular FN, and are dispensable for development when individually genetically ablated(Schwarzbauer 
and DeSimone, 2011). Additionally, the EDA and EDB regions are highly expressed during blood 
vessel development, and downregulated postnatally(Ffrench-Constant and Hynes, 1989; Ffrench-
Constant et al., 1989). These domains are then upregulated during wound healing, suggesting they 
might function in cell migration(Ffrench-Constant et al., 1989). Further studies show that EDA-null 
mice exhibit blunted wound healing and reduced lifespan(Muro et al., 2003). Additionally, EDA-null 
mice show reduced atherosclerotic burden and lower cholesterol in VLDL particles(Tan et al., 2004). 
EDA is dispensable for ECM formation(Muro et al., 2003), so taken together, these results suggest a 
signaling, rather than structural, role for the EDA domain of FN. Interestingly, when both the EDA and 
EDB domains are removed from FN, the result is embryonic lethal by E10.5(Astrof et al., 2007). 
Embryonic death comes as a result of massive cardiovascular defects, including posterior and cranial 
hemorrhage, defective embryonic angiogenesis, and poor heart cushion formation(Astrof et al., 
2007). Again, these mutations did not affect the deposition of FN matrix, suggesting a signaling role 
for EDA and EDB during development. The V region is also intimately involved with cardiovascular 
biology, as FN dimers missing the V region in both subunits are not secreted, and are degraded in the 
ER(Schwarzbauer and DeSimone, 2011). V0-V+ FN dimers, however, are efficiently secreted, and 
previous work suggests that these dimers are easily incorporated into fibrin clots in the 
bloodstream(Wilson and Schwarzbauer, 1992). FN and its alternative spliceforms are critical to 
vascular biology, participating in a wide range of functions during development, physiology, and 
disease. Though many mechanisms of FN function are understood, more work is needed to 
determine the precise functions of FN spliceforms, as well as the exact function of its complex domain 
structure.  
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Figure 1.1 Shear stress levels are variable throughout the vasculature 
 
 
 
 
Illustration demonstrating relative levels of shear stress throughout the vasculature. Arterial shear 
stress levels are higher than venous levels, and larger vessels have lower shear than smaller 
vessels.  
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Figure 1.2 Two main types of flow exist in the vasculature: laminar and disturbed flow 
 
Laminar flow occurs where vessel gemoetry is straight and uniform, whereas disturbed flow occurs 
where vessels bifurcate or curve highly. The different types of flow elicit different endothelial 
responses. Responses to laminar flow, termed “atheroprotective” include EC alignment in the 
direction of flow, stress fiber formation, and KLF2 expression, which leads to anti-inflammatory gene 
expression. Disturbed flow responses, termed “atheroprone” are more inflammatory and include NF-
κB activation and associated transcription. Additionally, ECs in areas of disturbed flow are more 
proliferative and produce more ROS than ECs in areas of laminar flow.   
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Figure 1.3 ECs express many mechanosensors 
 
 
 
These sensors can be divided into luminal, junctional, and basal mechanosensors. Luminal 
mechanosensors include G-protein coupled receptors (GPCRs, including the sphingosine 1-
phosphate receptor 1, S1P1, and the bradykinin B2 receptor) and heterotrimeric G-proteins (namely, 
Gαq/11), ion channels (including TRPV4, TRPP2, TRPC1, Piezo1 and Piezo2), microtubule-based 
primary cilia (which associated with the ion channels PKD1 and PKD1), the glycocalyx (where 
Syndecan-1 and -4, as well as heparin sulfate glycosaminoglycans are involved in shear signaling), 
and protein-coated membrane pits called caveolae (given structure by Caveolin 1-3 and Cavin 1-3). 
The known junctional mechanosensors, PECAM-1, VE-Cadherin, and VEGFR2, form a 
mechanosensory complex that elicits many signaling pathways as a response to shear. The basal 
mechanosensors consist of the integrins, which sense ECM type and substrate stiffness, all while 
integrating signaling pathways originating from other mechanosensors.   
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Figure 1.4 The junctional mechanosensory complex regulates cytoskeletal stiffening and 
inflammatory signaling in response to force 
 
 
 
Force on PECAM-1 activates phosphoinositide 3-kinase (PI3K), which is required for downstream 
activation of integrins. ECM-dependent integrin activation occurs, with fibronectin (FN) bound 
integrins positively regulating cellular stiffness through GEF-H1/LARG-RhoA signaling. Collagen (CL) 
bound integrins have the opposite affect; cellular stiffness is negatively regulated downstream of CL-
bound integrins through a protein kinase A (PKA)-phospho-RhoA pathway. Additionally, Rac1 is 
activated downstream of force on PECAM-1, which leads to increased inflamatory ROS production. 
Additonally, shear stress activates FN-bound integrins, leading to NF-κB activation, ICAM-1 and 
VCAM-1 expression, and an increase in moncyte adhesion to “activated” ECs.   
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Figure 1.5 Domain structure of the junctional mechanosensors 
 
 
 
The extracellular domain of PECAM-1 is comprised of 6 immunoglobulin (Ig)-like repeats, which 
participate in homophilic binding with other PECAM-1 molecules on neighboring ECs. These Ig-like 
repeats are linked by a transmembrane (TM) domain to the intracellular domain. The intracellular 
domain contains two immunoreceptor tyrosine-based inhibitory motif (ITIM) domains, which contain 
critical tyrosines that are rapidly phosphorylated at the onset of shear. VE-Cadherin, a classical 
cadherin, has an extracellular domain comprised of 5 cadherin domains, which mediate adhesion, 
and features p120 and β-catenin binding sites on its intracellular domain. These intracellular domains 
interact with p120 and β-catenin, mediating VE-Cadherin binding to the cytoskeleton. VEGFR2, a 
receptor tyrosine kinase has 7 Ig-like repeats in its extracellular domain. The intracellular domain 
contains two tyrosine kinase (TK) domains that interact with downstream effectors. Critically, 
tyrosines 801 and 1175 bind PI3K upon stimulation of the receptor. Mutation of these tyrosines blunts 
the cellular response to shear.    
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Figure 1.6 Integration of approaches is necessary for determining the precise function of 
various mechanosensors 
 
 
 
Methods available for the study of mechanosensing range from reductionist biophysical experiments 
to in vivo hemodynamic modification. Magnetic beads are used to apply force directly to putative 
mechanosensors, and can be useful for directly determing mechanosensitivity of a protein. In vitro 
shear stress experiments are useful for determining mechanoresponsiveness of proteins in the 
context of an endothelial monolayer, while in vivo experiments determine whether information gained 
using the aforementioned reductionist approaches is physiologically relevant. 
  
 
 
41 
Figure 1.7 Domain structure of the ShcA family of proteins 
 
 
The ShcA family of proteins consists of three members: p66Shc, p52Shc, and p46Shc. These 
proteins all share a similar structure, composed of a PTB domain and an SH2 domain connected by a 
CH1 domain. The size difference between the proteins is determined by the N-terminal CH2 domain, 
which is longest in p66Shc. The PTB an SH2 domains mediate interactions with phosphotyrosines on 
RTKs and other proteins. Several amino acids are also phosphorylated. These are Tyr239/240 and 
Tyr317 in the CH1 domain, and Ser36 in the CH2 domain of p66Shc. Importantly, the tyrosines of the 
CH1 domain are phosphorylated by acute application of shear stress in a process that requires 
VEGFR2 and Src kinase activities. The Ser36 of p66Shc is phosphorylated in response to oxidant 
stress, and is involved with apoptosis pathways (see Chapter 4 for more information).  
  
 
 
42 
Figure 1.8 Domain structure of Fibronectin 
 
Fibronectin is a large glycoprotein that mainly consists of three types of domain: FNI, FNII, and FNIII. 
These domains combine to confer many activities on FN. A 70 kDa fragment composed of FNI1-5 
resides at the N-terminus of the protein, and participates in FN assembly. FNIII1-2 are also important 
for FN assembly, while FNIII9-10 provide a binding site for integrins known as the RGD domain. 
Alternative spliceforms of FN can be made by adding or omitting Extra Domain A, Extra Domain B, 
and varying lengths of the Variable Region.  
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Chapter 2 Haemodynamics Regulate Fibronectin Assembly via PECAM 
 
OVERVIEW 
Fibronectin (FN) assembly and fibrillogenesis are critically important in both development and 
the adult organism, but their importance in vascular functions is not fully understood. Here we identify 
a novel pathway by which haemodynamic forces regulate FN assembly and fibrillogenesis during 
vascular remodelling. Induction of disturbed shear stress in vivo and in vitro resulted in complex FN 
fibril assembly that was dependent on the mechanosensor PECAM. Loss of PECAM also inhibited 
the cell-intrinsic ability to remodel FN. Gain- and loss-of-function experiments revealed that PECAM-
dependent RhoA activation is required for FN assembly. Furthermore, PECAM-/- mice exhibited 
reduced levels of active β1 integrin that were responsible for reduced RhoA activation and 
downstream FN assembly. These data identify a new pathway by which endothelial 
mechanotransduction regulates FN assembly and flow-mediated vascular remodelling.   
 
 
INTRODUCTION 
The extracellular matrix (ECM) is critical for a host of physiological processes. Not simply a 
structural scaffold, the ECM is critical for a number of cellular functions, including proliferation and 
survival(Chiang et al., 2009a; Choi and Hynes, 1979; McKeown-Longo and Mosher, 1983). 
Specifically in the vasculature, the ECM plays an important role in capillary morphogenesis and 
vascular tube stabilization(Ambesi et al., 2005; Davis and Senger, 2005; Zhou et al., 2008). A major 
constituent of the ECM in many tissues is fibronectin (FN), which exists in both plasma and cellular 
forms(Schwarzbauer and DeSimone, 2011). FN is a glycoprotein consisting of multiple binding 
domains for a plethora of proteins, including integrins, fibrin, collagen, heparin and other FN 
molecules(Schwarzbauer and DeSimone, 2011). FN is indispensable for development and, 
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interestingly, mice that lack FN expression are embryonic lethal due to cardiovascular defects(E. L. 
George et al., 1997; 1993). FN also plays an important role during pathological processes: during 
early atherogenesis, FN deposition is promoted in areas of disturbed flow and is associated with 
endothelial dysfunction(Collins et al., 2014; Orr et al., 2007; 2006a; 2008). 
FN monomers are soluble, and when assembled, form highly adhesive, insoluble fibrils. 
Polymerisation of FN into the ECM is important for both development and adult physiology. FN 
fibrillogenesis is essential for cleft formation during epithelial branching, the process by which nascent 
salivary glands begin developing(Sakai et al., 2003). FN fibrils also provide a mesodermal guidance 
cue during gastrulation(Darribère and Schwarzbauer, 2000; D. L. Shi et al., 1989). Injection of an 
RGD peptide blocks FN fibrillogenesis in the amphibian blastocoel cell roof, leading to a loss of 
directionality in mesodermal migration(Winklbauer and Nagel, 1991; Winklbauer and Stoltz, 1995). In 
adult physiology, mutations in the Hep-II and Hep-III domains of FN are present in carriers of 
glomerulopathy with FN deposits (GFND)(Castelletti et al., 2008). These mutations occur in regions of 
FN that are critical for fibrillogenesis, implicating impaired FN assembly in the progression of GFND. 
Additionally, FN fibrillogenesis regulates the remodeling and organization of other ECM molecules, as 
blocking FN polymerization also blocks collagen (CL) polymerization(F. Shi et al., 2010). FN 
assembly is a complex process that involves FN binding with integrins, an increase in FN-FN 
interaction, and conversion to deoxycholate (DOC) insoluble FN fibrils(Choi and Hynes, 1979; 
Schwarzbauer and DeSimone, 2011). The integrin binding step is primarily mediated by the FN 
binding integrin α5β1, which binds the RGD sites on FN molecules and increases clustering after 
binding occurs(Huveneers et al., 2008; Schwarzbauer and DeSimone, 2011). The small GTPase 
RhoA is also required for interaction of FN proteins. RhoA activity, and downstream activation of 
ROCK, increases cell contractility which acts upon FN proteins through α5β1 integrins, opening up 
cryptic binding sites in FN(Zhong et al., 1998). FN dimers assemble into fibrils that are eventually 
augmented to become large, DOC-insoluble FN polymers that make up the ECM. Although a great 
deal is known about the process of FN assembly, its importance in cardiovascular biology is 
incompletely understood. FN assembly is required for some endothelial functions, like network 
formation and proliferation(Ambesi et al., 2005; Davis and Senger, 2005; Zhou et al., 2008). 
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Assembled FN also regulates phenotypic plasticity in smooth muscle cells(Chiang et al., 2009a; F. 
Shi et al., 2014). Early studies suggested that ECs are involved in remodeling FN in the basal lamina 
and that FN organization, similar to actin stress fiber organization, shows flow dependency(AR et al., 
1985; Jinguji and Fujiwara, 1994). In the descending aorta, an area of the vasculature that 
experiences laminar flow, FN fibrils are thick and align in the direction of flow. However, at the renal 
artery bifurcation, an area of disturbed flow, FN fibrils are randomly distributed(Jinguji and Fujiwara, 
1994). The role of FN assembly in vessel function was more definitively tested using a peptide that 
inhibits FN polymerization: when this peptide was utilised in a mouse model of partial carotid artery 
ligation (CAL), it inhibited intima-media thickening (IMT) and flow-mediated vascular 
remodeling(Chiang et al., 2009a).  
Vascular remodeling resulting from CAL is driven by haemodynamic forces, as CAL induces 
chronic disturbed flow in the ligated carotid artery(Z. Chen and Tzima, 2009; Chiang et al., 2009a; 
Nam et al., 2009). Although it is appreciated that shear stress sensing by ECs is a major driving force 
for vascular remodeling, the molecular mechanisms by which endothelial mechanosignaling leads to 
vascular remodeling are unknown. We have previously shown that the cell adhesion molecule, 
PECAM, is a member of an endothelial mechanosensory complex. This complex is necessary and 
sufficient for endothelial mechanosignalling, including alignment of stress fibers in the direction of 
flow(Tzima et al., 2005). In vivo, PECAM is necessary for vascular remodeling after CAL(Z. Chen and 
Tzima, 2009), as well as collateral remodelling in response to hindlimb ischaemia(Z. Chen et al., 
2010). Using a magnetic tweezers system, we have shown that local force application on PECAM 
results in a global mechanotransduction response that involves remodeling of the actin cytoskeleton 
and activation of mechanical stiffening(Collins et al., 2012). However, very little is known about the 
specific mechanisms underlying shear induced FN assembly. Here, we show that haemodynamics, 
and shear stress in particular, regulate FN assembly in vitro and in vivo in a PECAM-dependent 
manner. Mechanistically, PECAM-dependent FN assembly requires RhoA and β1 integrin activation. 
These data identify a new pathway by which endothelial mechanotransduction regulates FN 
assembly and flow-mediated vascular remodeling.   
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RESULTS  
In vivo flow-mediated FN remodeling is dependent on PECAM 
Previous work from our group has shown that PECAM-/- mice exhibit impaired flow-mediated vascular 
remodeling and reduced IMT after partial CAL(Z. Chen and Tzima, 2009). Since FN assembly is 
required for IMT(Chiang et al., 2009a), we hypothesized that flow-mediated vascular remodeling, FN 
assembly and PECAM mechanotransduction are connected. To test this, we first examined if FN 
assembly is sensitive to changes in haemodynamics. We subjected WT mice to partial CAL or sham 
surgery, and after 3 weeks, left common carotid arteries (LCA) were mounted en face and 
immunostained with an anti-FN antibody. Sham LCAs, which experience laminar shear stress, 
exhibited long FN fibrils that were aligned in the direction of flow (Figure 2.1A and C). In contrast, 
exposure of LCAs to low and disturbed flow due to ligation resulted in formation of thicker and 
randomly-oriented FN fibrils (Figure 2.1A and C). Interestingly, LCAs from PECAM-/- mice displayed 
differences in FN organization compared to WT LCAs in both sham and ligated conditions (Figure 
2.1A and D). Under laminar flow conditions present in sham LCAs, PECAM-/- animals had few and 
randomly oriented FN fibrils; even after changing flow in response to ligation, PECAM-/- LCAs failed to 
show the complex FN fibrils evident in the WT ligated LCAs, suggesting that absence of PECAM 
results in impaired flow-mediated FN assembly and remodeling (Figure 2.1B). Consistent with the 
results in WT and PECAM-/- carotid arteries, the WT descending aorta displays a high degree of FN 
assembly, whereas PECAM-/- descending aortas lack complex FN assembly (Figure 2.7). Given that 
the FN matrix serves as a template for deposition of other ECM proteins(Kubow et al., 2015), we also 
examined the distribution of collagen I (CL) in sham and ligated LCAs. Similar to the observations 
made for FN fibrils, PECAM-/- aortas were characterized by wispy and fewer CL fibrils (Figure 2.8).  
Disturbed shear stress induces FN assembly in a PECAM-dependent manner. 
To determine whether the observed deficit in FN assembly in KO mice is an endothelial-
specific phenotype, we exposed PECAM knockout (KO) and PECAM reconstituted (RC) ECs to 
oscillatory shear stress, followed by visualization of FN fibrils (Figure 2.2A and B). Striking differences 
in FN assembly were observed between genotypes.  RC cells showed a high degree of FN fibril 
formation in static conditions and responded to shear stress by increasing fibril formation 3-fold. In 
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contrast, KO cells did not form any detectable FN fibrils in either static or sheared conditions. The few 
FN deposits that did form resembled the punctate nature of FN deposits observed in PECAM-/- mice 
(Figure 2.1). Similar results were obtained when ECs were immunostained for CL (Figure 2.8). 
Interestingly, KO ECs also exhibited reduced FN mRNA levels, suggesting that PECAM is also 
important for FN expression (Figure 2.9).  
FN assembly renders fibrils insoluble in DOC-containing lysis buffer, making DOC insolubility 
an appropriate biochemical method for assaying the degree of FN assembly. To complement our 
immunofluorescence data, we performed DOC-solubility experiments. RC and KO lysates were 
fractionated using a DOC-containing lysis buffer after application of shear stress, followed by 
immunoblotting for FN (Figure 2.2C). In static conditions, RC cells showed 5-fold more assembled FN 
than KO cells. Application of shear increased the amount of assembled FN 2-fold in RC cells, while 
no increase in assembled FN was observed in sheared KO cells. These results are consistent with 
the immunofluorescence data and collectively show that PECAM is required for both basal and shear-
dependent FN assembly and remodeling in ECs.  
PECAM is required for the intrinsic ability to assemble FN 
To determine whether PECAM is required for the cell-intrinsic ability to assemble FN, we 
utilized a fibrillogenesis assay whereby RC and KO cells were supplied with FITC-FN as ECM, 
soluble media supplement, or both, followed by fixation and fluorescence microscopy (Figure 2.3). 
Under all three conditions, RC cells displayed increased accumulation of FITC-FN into fibrils 
compared to KO cells. Whether FITC-FN was provided as ECM glass coating or media supplement, 
RC cells assembled more extensive networks of FN fibrils. KO cells organized the FN into punctate 
deposits, but failed to form FN fibrils. When FN was provided as both a glass coating and a media 
supplement, RC cells demonstrated augmented assembly of fibrillar FN matrix. Under these same 
conditions, KO cells assembled significantly less FITC-FN-containing fibrillar matrix that was 
characterized by primarily punctate deposits of FN. Together, these data suggest that PECAM is 
required for EC fibrillar FN matrix assembly independent of the expression of endogenous FN.  
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Disturbed shear stress regulates PECAM-dependent FN assembly via a β1-integrin-RhoA 
pathway 
FN assembly in fibroblasts requires actomyosin signaling via the Rho-ROCK 
pathway(Schwarzbauer and DeSimone, 2011; Singh et al., 2010; Zhong et al., 1998). Notably, RhoA-
dependent contractility is required for exposure of a cryptic self-assembly site in the FN protein(Zhong 
et al., 1998). Additionally, knockdown of ROCK isoforms I or II leads to reduced FN matrix assembly 
and altered MLC localization, further suggesting a role for RhoA-dependent contractility in FN 
assembly(Yoneda et al., 2007). Since KO cells lack the ability to properly assemble FN into fibrils, we 
examined the role of the Rho pathway in our system. We assayed RhoA activation levels in RC and 
KO cells by RBD pulldown, which uses the Rho binding domain from the Rhotekin protein to bind and 
isolate GTP bound RhoA. As shown in Figure 4a and 4b, KO ECs have reduced levels of active RhoA 
compared to RC cells.  The observed reduction in Rho-GTP levels correlates with lower DOC-soluble 
FN in the KO cells. To determine whether RhoA activation levels were causative for FN assembly, we 
performed gain-and loss-of-function experiments. Firstly, to determine if low FN assembly levels 
could be rescued by stimulation of RhoA activity, we treated KO cells with lysophosphatidic acid 
(LPA) to activate RhoA(Anliker and Chun, 2004), followed by RBD pulldown and DOC insolubility 
assays (Figure 2.4C and D). LPA stimulation increased Rho-GTP levels approximately 140%, as 
expected, which was also accompanied by a concomitant and comparable increase in FN assembly 
compared to unstimulated cells. RhoA knockdown experiments were also performed in RC cells to 
determine whether decreased expression of RhoA reduces levels of assembled FN (Figure 2.4E and 
F). Indeed, Rho-GTP levels were significantly reduced after RhoA knockdown, leading to a 60% 
reduction in DOC-soluble FN levels. Overall, these gain-of-function and loss-of-function studies show 
that PECAM-dependent RhoA activation is necessary for FN assembly in ECs.  
β1 integrin is a major FN binding integrin, and is reported to be the master integrin involved in 
stretching and assembling individual FN monomers into FN fibrils(Huveneers et al., 2008). Given the 
deficit in FN assembly in the absence of PECAM, we examined the activation status of β1 integrins in 
the absence of PECAM. We performed immunofluorescence staining using an antibody specific for 
active β1 integrins in WT and PECAM-/- carotid arteries. Imaging revealed a stark difference between 
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the two genotypes (Figure 2.5A). WT carotids displayed high levels of β1 integrin activation, 
concentrated in the endothelial layer, compared to PECAM-/- carotids. These results raise the 
intriguing possibility that levels of active integrins are connected to both activation of RhoA and 
downstream FN assembly. To test this, we performed β1 integrin knockdown experiments (Figure 
2.5B). In RC cells treated with β1 integrin siRNA, Rho-GTP levels were reduced by 70% compared to 
control siRNA transfected ECs. This was accompanied by a comparable reduction in levels of DOC-
insoluble FN, indicative of reduced FN assembly. In complementary experiments, when using a β1 
integrin function-blocking antibody we also saw reduced levels of DOC-insoluble FN (Figure 2.5C). 
Overall, these data show that PECAM-dependent β1 integrin activation is required for RhoA activation 
and downstream FN assembly in ECs.  
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DISCUSSION 
We have previously shown that PECAM knockout mice exhibit impaired flow-mediated 
vascular remodeling and IMT in response to CAL(Z. Chen and Tzima, 2009). Similarly, mice treated 
with a FN polymerization inhibitor are also characterized by reduced IMT and vascular 
remodeling(Chiang et al., 2009a). Although endothelial responses to shear stress are known to 
regulate expression and deposition of ECM components(Feaver et al., 2010; Gelfand et al., 2011; 
Green et al., 2014; Orr et al., 2006a), virtually nothing is known about the role of shear stress in the 
regulation of FN assembly. We hypothesized that PECAM, a known endothelial mechanosensor, is 
important for regulation of the organization of the subendothelial ECM, especially in response to 
shear stress. Our results here provide a mechanistic link between mechanosensing and FN 
organization during flow-mediated vascular remodeling. Using both PECAM knockout ECs and mice, 
we show that PECAM regulates FN fibrillogenesis in a RhoA- and integrin β1-dependent pathway 
(Figure 2.6).   
CAL is a method for modification of the carotid artery hemodynamic environment. Proximal to 
the carotid bifurcation, the left carotid artery normally experiences laminar flow. After CAL, blood flow 
in the left carotid artery becomes disturbed, leading to IMT and vascular remodeling in order to 
normalize shear stress. A main result from the present study is the failure of PECAM knockout mice 
to assemble FN after CAL. Other studies have focused on the role of haemodynamics in the 
regulation of expression of ECM components. Atheroprone areas of the vasculature exhibit increased 
deposition of FN and ECs exposed to disturbed flow exhibit increased FN expression(Feaver et al., 
2010; Gelfand et al., 2011; Green et al., 2014; Orr et al., 2006a; 2005). Not surprisingly, the role of 
FN in inflammation and atherosclerosis is rather complex: while FN promotes increased plaque area, 
it has also been shown to promote formation of the protective fibrous cap, which in humans prevents 
plaque rupture(Rohwedder et al., 2012). Our results are in agreement and extend these findings to 
show increased FN deposition in areas of disturbed flow in response to CAL. Importantly, PECAM 
knockout mice, which lack much of their endothelial shear sensing capability, deposit very little FN 
and exhibit almost no fibril assembly. The observed deficiency in FN fibrillogenesis in the absence of 
PECAM could be the result of two causes: a reduction in FN expression or a lack of endothelial 
 
 
51 
capacity to physically assemble the fibrils. Our results show that both are the case in PECAM KO 
ECs. We observe that PECAM KO cells exhibit deficient basal FN mRNA expression, consistent with 
previous work showing that atheroprone shear stress turns on transcription of FN via a PECAM/ 
NFB-dependent pathway in ApoE KO mice(Feaver et al., 2010). We also show that when provided 
exogenous FN, KO cells are unable to assemble the FN into fibrils, demonstrating an intrinsic inability 
of KO cells to remodel FN, independent of the expression of FN.  
RhoA-mediated contractility is thought to be the physical force that stretches FN proteins and 
assembles them into fibrils(Fernandez-Sauze et al., 2009; Singh et al., 2010; Zhong et al., 1998). We 
show here that PECAM is required for RhoA activity in ECs, as PECAM KO ECs display reduced 
levels of active, GTP-bound RhoA. Importantly, gain-of-function studies show that stimulation of RhoA 
activity in KO ECs leads to increased FN assembly. Reciprocally, loss-of-function studies using 
siRNA-mediated knockdown of RhoA in PECAM-expressing ECs show that abrogation of Rho 
signaling results in significant attenuation of FN assembly. Since β1 integrins are the main integrins 
that bind to the RGD domain of FN and shear stress leads to increased integrin activation and 
increased binding to the ECM(Tzima et al., 2001), we examined the activation of β1 integrins in 
PECAM-/- carotid arteries.  We found that PECAM is required for increased levels of active β1 
integrins. A causative role for β1 integrins in FN assembly was shown using two complementary 
approaches: use of siRNA-mediated knockdown and function blocking antibodies, both of which 
resulted in reduced RhoA activation and downstream FN assembly. This demonstrates a requirement 
for β1 integrin in PECAM-mediated FN assembly.  
Taken together with previous studies, our results here provide a mechanistic link between 
endothelial mechanosensing, FN assembly, and flow-mediated vascular remodeling. Although the 
observation that FN fiber organization shows an apparent flow dependency was made more than 20 
years ago, the molecular mechanisms of this process remained a mystery. We now show that shear 
stress serves as a potent activator of β1 integrins and RhoA signaling through a PECAM-dependent 
mechanism that, in turn, drives FN (and CL) assembly. Our results show that increased FN assembly 
resulting from chronic disturbed flow in vitro and in vivo requires PECAM, indicating that FN assembly 
is a mechanoresponsive event. Previous work from our lab described a requirement for PECAM in 
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flow-induced inflammation, IMT and vascular remodeling in a model of partial carotid ligation(Z. Chen 
and Tzima, 2009). Using two dfferent models of atherosclerosis (ApoE KO and LDLR KO), previous 
studies have shown that the functions of PECAM depend on the type of shear stress that vessels 
experience, such that PECAM promotes atherosclerosis in areas of disturbed shear stress while it 
prevents atherosclerosis in areas of laminar shear stress(Goel et al., 2008; Harrison et al., 2013b; 
Harry et al., 2008; Stevens et al., 2008). The present study shows that under disturbed flow regimes, 
PECAM promotes FN assembly. Given that FN assembly is required for vascular remodeling and 
attendant inflammation(Chiang et al., 2009a), and that haemodynamics regulate FN 
deposition(Feaver et al., 2010), increased FN assembly may be a hallmark of vessel inflammation 
caused by PECAM signaling in response to disturbed flow. It is therefore tempting to hypothesize that 
PECAM- dependent FN assembly underlies inflammatory remodeling, such as IMT and 
atherosclerosis, in the vasculature. However, further studies are needed to delineate if FN assembly 
begets endothelial inflammation, or whether the converse is true and endothelial inflammation begets 
FN assembly. Further research in this area could lead to targeted therapies to atherosclerotic areas, 
where plaque progression could be slowed or fibrous caps could be stabilized through mechanisms 
that block or induce FN assembly, respectively.  
 
MATERIALS AND METHODS 
Cell culture, shear stress assays PECAM-/- (KO) cells and cells reconstituted (RC) with full-length 
PECAM were prepared as described(Graesser et al., 2002). Levels of PECAM in reconstituted cells 
are similar to wild-type levels. Primary bovine aortic ECs (BAEC) were obtained from VEC 
Technologies (Rensselaer, NY). Nearly confluent cells were incubated in starvation media (DMEM 
with 0.5% fetal bovine serum and 1% penicillin/streptomycin) overnight before shear stress 
experiments. Cells on fibronectin-coated glass slides were mounted in a parallel plate flow chamber 
connected to a NE-1050 bi-directional syringe pump by rigid wall tubing (New Era Pump Systems, 
Inc., Farmingdale, NY). Cells were exposed to oscillatory flow for 24 hours at ± 6.5 Dynes/cm2 with a 
frequency of 1 Hz. Flowed slides were washed with cold phosphate buffered saline (PBS) for Rho-
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GTPase pulldown, deoxycholate (DOC) solubility assays or fixed with 1% formaldehyde for 10min for 
immunostaining as described below.  Cells not subjected to shear stress were used as static controls.  
DOC solubility assay Cells were washed with cold PBS for 3 times, and lysed in cold 2% DOC 
buffer(Wierzbicka-Patynowski et al., 2004). Cell lysates were processed with a bead homogenizer for 
30s and aliquoted. To separate DOC-insoluble fraction, an aliquot was centrifuged at 16000rpm in 
4ºC for 15m. The pellet was dissolved in SDS loading buffer and DOC-insoluble proteins were 
examined with Western blot assay.  BCA assays were performed to ensure equal protein loading, and 
DOC-insoluble vimentin is used as a loading control protein.  
Western Blotting Samples were loaded on to pre-cast 4-15% polyacrylamide gradient gels (Bio-Rad, 
Hercules, CA). Using MOPS running buffer, electrophoresis was carried out at 200V for 30 minutes, 
followed by transfer to a nitrocellulose membrane. Membranes were blocked for 1 hour in 50% Li-Cor 
blocking buffer in 1X PBS (Li-Cor, Lincoln, NE). Membranes were then probed with primary 
antibodies overnight at 4°C in 50% Li-Cor blocking buffer in 1X PBS. Primary Antibodies: Goat anti-β1 
integrin (1:200; Santa Cruz Biotechnology, Dallas, TX; SC-6622), Rabbit anti-Fibronectin (1:1000; 
Sigma-Aldrich Inc., St. Louis, MO; F3648), Mouse anti-RhoA (1:500; Santa Cruz Biotechnology, 
Dallas, TX; SC-418), Mouse anti-GAPDH (1:1000; Millipore, Billerica, MA; MAB374), Goat anti-
vimentin (1:200; Santa Cruz Biotechnology, Dallas, TX; SC-7559). Membranes were then probed 
using fluorescent secondary antibodies for 1 hour at room temperature, followed by scanning on a Li-
Cor Odyssey scanner. Fluorescent secondary antibodies were all used at a 1:2000 dilution.  
Quantitative PCR Quantitative PCR was performed using SYBR Green 2X master mix as per 
manufacturer’s instructions (Thermo Fisher Scientific, Waltham, MA). Primer Sequences: Fibronectin- 
F: TGGTTTGGTCTGGGATCAAT; R: ACAGTGCTGCAGGTCAGATG. GAPDH- F: 
CATGTTTGTGATGGGTGTGA, R: CTAAGCAGTTGGTGGTGCAG. Cycler Conditions: 5 minutes at 
95°C, followed by 45 cycles of: 20 seconds at 94°C, 20 seconds at 60°C, and 20 seconds at 72°C. 
The last step of the cycle was a melt curve to test primer efficiency. qPCR peaks were quantified 
using the delta-delta Ct method.  
FITC-Fibronectin assay 1mg/ml fibronectin stock was conjugated to fluorescein isothiocyanate 
isomer I (Sigma-Aldrich Inc., St. Louis, MO) as per manufacturer instructions. After dialysis, protein 
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concentration was determined using a BCA assay. Slides were then coated with 10μg/ml FITC-FN or 
0.1% gelatin for 1 hour at room temperature. PECAM RC or PECAM KO cells were plated and 
allowed to grow to confluence, after which they were serum starved for 16h. After serum starvation, 
reduced serum media was either replaced with fresh media or fresh media with 10μg/ml FITC-FN 
added. Cells were incubated with FITC-FN for 24h, followed by fixation and mounting with DAPI-
containing media.  
Rho-GTPase assay Cells were plated on fibronectin-coated glass slides and allowed to grow 
overnight to 95% confluency. Rho-GTPase pulldown was performed with RBD-conjugated beads per 
manufacturer’s instructions (Cytoskeleton Inc., Denver CO). To stimulate Rho-GTP, lysophosphatidic 
acid (LPA) (Sigma-Aldrich Inc., St. Louis, MO) was dissolved in deionized water and added to cell 
media at 20µM final concentration. Deionized water was added to control cells. To inactivate Rho-
GTP, cells were transfected with RhoA siRNA as described below. 
siRNA transfection The following siRNA duplexes were synthesized (Dharmacon Inc., Lafayette, 
CO) : bovine β1 integrin CUUAAUAUGUGGAGGAAAUUU; bovine RhoA: 
CUAUGUGGCAGAUAUUGAdTdT BAECs were plated in 100mm dishes to grow to 30-40% 
confluence in full media (DMEM with 10% FBS and 1% penicillin/streptomycin). 25µl 20µM siRNA 
was mixed with 500µl 2x HBS pH 7.05, followed by mixing with 30µl 2.5M CaCl2. The mixture was 
incubated at room temperature for 20min to form siRNA-calcium phosphate complex. The siRNA 
complex was added to the cell media dropwise. The cells were incubated with siRNA complex 
overnight, trypsinized and re-plated to a fibronectin-coated dish, and culture in full media. Total β1 
integrin protein was monitored before, 24, 48 and 72 hours after transfection. Cells were harvested 
for Rho-GTPase assays or DOC solubility assay 48 hours after the initial transfection.  
Immunofluorescence Cells subjected to shear stress were washed 3 times with cold PBS, followed 
by fixation with 1% formaldehyde for 10min.  Cells were permeabilized with 0.3% Trition X-100 in tris-
buffered saline (TBS) for 3m, and blocked with 0.5% non-fat dry milk, 1% BSA and 0.3% Triton X-100 
in TBS for 60m. A primary antibody, fibronectin (1:200; Sigma-Aldrich Inc.,  St. Louis, MO; F3648), 
active β1-integrin (clone 9EG7, 1:100, BD, 553715; or clone HUTS4 1:100; Millipore, Billerica, MA; 
MAB2079Z) or beta-catenin (1:100, Sigma-Aldrich Inc., St. Louis, MO; C7082), was incubated with 
 
 
55 
the cells overnight in 4ºC, followed by the incubation with Alexa 568-labeled goat anti-rabbit or mouse 
antibodies (1:200, Life Technologies, Grand Island, NY). Images were taken with a Carl-Zeiss 700 
laser confocal microscope. 
Carotid artery ligation model Wild-type C57/BL6 (PECAM+/+) mice were purchased from Jackson 
Laboratories. PECAM-/- C57BL/6 mice were kindly provided by Dr. P. Newman (Blood Research 
Institute, Blood Center of Wisconsin, Milwaukee), bred in house and used in accordance with the 
guideline of the National Institute of Health and for the care and use of laboratory animals (approved 
by the Institutional Animal Care and Use Committees of the University of North Carolina at Chapel 
Hill). Male PECAM -/- and age-matched littermates (WT, 10-14 weeks) were used for all experiments. 
Blood flow reduction in the left common carotid artery (LCA) and blood flow measurements were 
performed as previously described(Z. Chen and Tzima, 2009; Korshunov and Berk, 2003).  The 
ligation operation closed internal, external and occipital carotid arteries, and left the thyroid artery 
open. Partial blood flow (5-10% within 3 weeks after surgery) remained in common carotid artery 
through the opening thyroid branch. The sham procedure consisted of vessel isolation and ligature 
placement without ligation.  
En face preparation of carotid arteries The common carotid arteries were perfusion-fixed with 1% 
paraformaldehyde for 10m and harvested 5 days or 3 weeks after carotid artery ligation. The 
adventitia was removed using surgical forceps. The remaining intimal-medial tissue of the carotid 
arteries was cut longitudinally and mounted flat on glass slides for immunofluorescence and imaging. 
En face tissue immunofluorescence En face mounted tissue samples were rehydrated with water 
for 10 minutes. The tissue was then permeabilized using Tris-Triton buffer (50mM Tris, 500mM NaCl, 
0.3% Triton X-100) for 1 hour, followed by 3 washes with water. Permeabilized tissue was then 
blocked using 0.5% non-fat dry milk and 1% BSA in TBST for 60 minutes at room temperature. 
Primary antibodies (Rabbit anti-FN, 1:100, Sigma F3648, St. Louis, MO; rat anti-VE-Cadherin, 1:50, 
BD Pharmingen 550548, Franklin Lakes, NJ, ; or rabbit anti-Collagen α1, 1:100, Abcam Ab292, 
Cambridge, UK) were then diluted in blocking buffer and incubated with the tissue overnight at 4°C. 
After primary antibody incubation, slides were washed 3 times with TBST. Secondary antibodies 
(Goat anti-rat Alexafluor 488, 1:100, A11006 Life Technologies; Goat anti-rabbit Alexafluor 568, 
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1:100, A11011 Life Technologies) were diluted in blocking buffer and incubated with the tissue for 60 
minutes at room temperature. The tissue was washed 3 times in TBST, and then mounted with 
VectaShield plus DAPI (Vector Labs, Burlingame, CA) and sealed with clear nail polish. Slides were 
imaged on a Zeiss 700 or Zeiss 710 confocal microscope.  
Percent Fibril Area Calculations and Fibril Angle Morphometry Grayscale images of fluorescently 
labeled FN were opened in Fiji image analysis software. The images were then adjusted using the 
threshold command with the “dark background” option selected. The threshold values were recorded 
and used across all images for each experiment. After thresholding, the analyze particles command 
was used, which produces the area of each fibril in an image. These fibril areas were added together 
to obtain the total fibril area. This area was then divided by the total image area, giving the percent 
fibril area. To obtain fibril angles, thresholding was performed, followed by analysis using the 
Directionality plugin in Fiji. Angles from 90 to -90 were analyzed, and the resulting particle 
frequencies were grouped together in 10-degree bins, followed by plotting in Microsoft Excel.  
β1 integrin function blocking studies  BAECs were grown to 95% confluence, followed by 4 hours 
of serum starvation in 0.5% FBS. BAECs were then treated with either 1μg/ml β1 integrin function 
blocking antibody AIIB2 (University of Iowa Hybridoma Bank) or 1μg/ml ChromPure mouse IgG 
(Jackson Immunoresearch Laboratories, West Grove, PA; 015-000-003) for 24 hours at 37° and 5% 
CO2. 
Statistical Analysis Results are described as mean ± SEM. Statistical tests were performed with 
Microsoft Excel analysis package, using Student’s t-test for 2 groups or one-way ANOVA followed by 
multiple comparisons with Tukey’s Honest Significance Difference test. Level of p<0.05 was 
considered significant. 
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Figure 2.1 PECAM is required for FN assembly in response to CAL 
 
 
WT and PECAM-/- mice were subjected to CAL. (A) 3 weeks after CAL, sham and ligated carotid 
arteries were harvested, mounted en face and stained for FN. (B) FN fibril area was quantified. Scale 
Bar = 20m; n=16 WT and 10 PECAM-/- mice. (C) WT FN fibril angle was analyzed in sham and 3-
week ligated LCAs n=3 sham and n=5 CAL. (D) KO FN fibril angle was analyzed in sham and 3-week 
ligated LCAs n=2 sham and n=3 CAL. 
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Figure 2.2 Disturbed shear stress induces PECAM-dependent FN assembly
RC and KO cells were subjected to flow or kept as static controls. (A) After flow, RC and KO cells 
were fixed and stained for FN, followed by (B) quantification of FN fibril area. (C) Representative 
western blots showing DOC-insoluble FN in RC and KO ECs before or after oscillatory shear stress. 
Quantification of DOC-insoluble FN relative to static RC lysates is shown, and was performed after 
normalization to vimentin. Scale bar in (A) is 20um. (A) and (B) n=5 independent experiments; (C) 
n=4 independent experiments.  
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Figure 2.3 PECAM is required for the intrinsic ability of ECs to remodel FN 
 
(A) FITC-conjugated FN was provided to static RC and KO cells as a tissue culture glass coat, media 
supplement, or both. Representative images are shown (FN was pseudocolored in red for clarity). 
Representative images are shown (FN was pseudocolored in red for clarity). Scale Bar=40m (B) 
Percent fibril area was also quantified. (A) and (B) n=3 independent experiments.  
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Figure 2.4 PECAM-dependent RhoA activity is required for FN assembly 
(A) RhoA-GTP levels in RC and KO cells were determined by RBD pulldown. FN assembly was 
assayed by DOC-insolubility. (B) Quantification of RhoA-GTP and DOC-insoluble FN is below. (C) KO 
cells were stimulated with LPA, a RhoA agonist. RhoA-GTP was determined by RBD pulldown and 
FN assembly was assayed by DOC-insolubility. (D) Quantification of RhoA-GTP and DOC-insoluble 
FN is below. (E) ECs were transfected with control or RhoA siRNA and Rho-GTP levels and DOC-
insuble FN were assayed. (F) Quantification of RhoA-GTP and DOC-insoluble FN is below. 
Experiments were performed in static cells. (A) and (B) n=4 independent experiments; (C) and (D) 
n=6 independent experiments; (E) and (F) n=4 independent experiments.  
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Figure 2.5 Role of Beta1 integrin activation in FN assembly 
(A) Active β1-integrin staining in cross sections of WT and PECAM-/- carotid arteries harvested 5 days 
post-CAL. Scale Bar=20m; n=3 independent experiments. (B) ECs were transfected with control or 
β1 integrin siRNA and levels of GTP-RhoA and DOC-insoluble FN were assayed and quantified. (C) 
ECs were incubated with control IgG or the β1 integrin function blocking antibody AIIB2 before 
determination of FN assembly by DOC-insolubility. (B) n=at least 3 independent experiments. (C) n=4 
independent experiments.  
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Figure 2.6 Disturbed flow regulates PECAM-dependent FN assembly through a Beta1 integrin-
RhoA pathway 
 
Distrubed flow regulates FN fibrillogenesis; mechanistically, this is dependent on PECAM-dependent 
activation of β1 integrins and RhoA.  
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Figure 2.7 PECAM-1 is required for FN assembly in the descending aorta 
 
WT and PECAM-/- aortas were mounted en face and stained for fibronectin. Scale Bar = 20μm, n=1 
mouse per genotype 
  
 
 
64 
Figure 2.8 PECAM-1 is required for shear-induced CL assembly 
 
 
(A) WT and PECAM-/- mice were subjected to CAL. 5 days after CAL, sham and ligated carotid 
arteries were harvested, mounted en face and stained for CL. CL fibril area was quantified. Scale bar 
= 30μm, Sham n = 5 WT and 4 PECAM-1-/- , 5d CAL n = 4 WT and 4 KO. (B) RC and KO cells were 
subjected to flow, followed by immunostaining for CL. CL fibril area was quantified. Scale bar = 10μm, 
n= 3 independent experiments. 
  
 
 
65 
Figure 2.9 PECAM-1 is required for FN expression 
 
mRNA was harvested from RC and KO cells, and qPCR was performed using primers specific to FN. 
n = 3 biological replicates for each genotype.  
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Chapter 3 The adaptor protein Shc is a major regulator of endothelial inflammation 
 
 
OVERVIEW 
Forces are critical regulators of vascular physiology and pathology. Shear stress, the 
frictional force of blood flowing over the endothelium, regulates both inflammatory and anti-
inflammatory signaling in ECs. The adaptor protein Shc is a central regulator of endothelial 
inflammation, and is phosphorylated upon the application of shear stress to ECs. The data in this 
chapter describe a role for Shc tyrosine phosphorylation in arteriogenesis. In mice expressing a 
phosphorylation-null Shc construct, arteriogenesis is blunted due to a reduction in collateral vessel 
growth. Additionally, this chapter demonstrates that Shc is required for atherogenesis, the chronic 
inflammatory condition by which atherosclerotic plaques form and develop. Critically, Shc is shown to 
be involved in atherogenesis in response to altered hemodynamics. Taken together, these results 
suggest that Shc may play a major role in vascular inflammation, and may present a target for future 
vascular therapeutics.  
 
 
INTRODUCTION 
Shear stress, which is the frictional force of blood flowing over the endothelium, is a critical regulator 
of cardiovascular physiology and pathology, influencing vascular tone, pruning of the vascular tree, 
and formation of atherosclerotic plaques(Boo and Jo, 2003; Davies, 1995; Hahn and Schwartz, 2009; 
Lucitti et al., 2007). Shear patterns fall into two broad categories: laminar and disturbed. Laminar, or 
atheroprotective, shear stress, is anti-inflammatory and occurs in uniform, straight areas of the 
vasculature. Laminar flow induces eNOS activation and NO production(Pan, 2009), endothelial 
expression of KLF2(Parmar et al., 2006), and alignment of ECs in the direction of flow(Tzima et al., 
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2005; 2001). Conversely, disturbed shear stress is highly inflammatory(Hahn and Schwartz, 2009). 
ECs do not align in the direction of flow, and instead retain a polygonal shape. Additionally, ROS 
production and NF-B activation occur, leading to expression of inflammatory adhesion markers like 
ICAM-1 and VCAM-1(Chatzizisis et al., 2007).  
 Endothelial inflammation underlies many physiological and pathological conditions in the 
vasculature. For example, inflammation directs the process of arteriogenesis, in which small collateral 
arterioles remodel and increase their size to resemble conductance arteries (Schaper and Scholz, 
2003; Sweet et al., 2013). Collateral vessels, which are arteriole-arteriole anastomoses, normally 
experience no net blood flow as a result of the flat pressure gradient between healthy arterial beds. 
Upon major vessel occlusion, the gradient tips and shear stress dramatically increases. This increase 
in shear stress induces endothelial inflammation, including NF-B activation, endothelial proliferation, 
and expression of ICAM-1, VCAM-1, and MCP-1(Z. Chen et al., 2010; Schaper, 2009; Sweet et al., 
2013).  In turn, leukocyte recruitment and SMC proliferation increase, leading to an increase in 
collateral size. Importantly, shear stress, not ischemia, is a major driver of arteriogenesis. The point at 
which shear stress becomes normalized determines the final size of remodeling collaterals(Schaper, 
2009). If shear is artificially increased, the collaterals grow larger as a result of higher shear 
forces(Eitenmüller et al., 2006).  
 Another result of endothelial inflammation is atherosclerosis, a decades-long inflammatory 
disease characterized by focal accumulation of cholesterol and immune cells under the 
endothelium(Chatzizisis et al., 2007; Hahn and Schwartz, 2009). The progression of atherosclerosis 
is associated with genetic and environmental factors, including family history, elevated levels of LDL 
and VLDL, smoking and diabetes(Green et al., 2014; Lusis, 2000). However, though many 
contributing factors are systemic, atherosclerotic plaque distribution is focal, which is thought to be 
due to the localization of low and disturbed flow to branch points and areas of high curvature in the 
vasculature(Chatzizisis et al., 2007; Hahn and Schwartz, 2009). Chronic disturbed shear contributes 
to the growth of atherosclerosis in a number of ways. Disturbed shear activates ECs through 
induction of NF-B(Hahn and Schwartz, 2009), sustaining this activation through deposition of 
fibronectin(Feaver et al., 2010). Moreover, disturbed shear represses eNOS expression in ECs, 
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leading to a reduction in NO production(Chatzizisis et al., 2007; Ziegler et al., 1998). Endothelial 
mechanosensing plays a central role in the regulation of atherosclerosis by disturbed flow. An 
endothelial mechanosensor, PECAM-1, has been implicated in the formation of atherosclerosis in the 
lesser curvature of the aortic arch, an area of the aorta exposed to chronic disturbed flow(Goel et al., 
2008; Harrison et al., 2013a; Harry et al., 2008; Stevens et al., 2008). Furthermore, acute induction of 
disturbed flow is sufficient to induce plaque formation in the carotid arteries of mice(Nam et al., 2009).  
 Playing a central role in the endothelial mechanosensory response is the adaptor protein 
ShcA, henceforth referred to as Shc. Shc is a ubiquitously expressed adaptor protein that has three 
isoforms, all differentiated by the length of their N-terminal tails: p46, p52, and p66 Shc(Wills and 
Jones, 2012). All isoforms of Shc share PTB-, CH1-, and SH2-domains. The PTB and SH2 domains 
mediate interaction with RTKs, while the CH1 contains critical phosphorylation sites at tyrosines 239, 
240, and 317 that mediate interactions with downstream effectors(Wills and Jones, 2012; L. Zhang et 
al., 2002). Shc is critical for cardiovascular development, as Shc knockout mice lack cardiovascular 
function due to malformed hearts(K. M. Lai and Pawson, 2000). ECs from these mice also fail to 
spread in culture due to improper RhoA function. Other studies have linked defects in heart 
development specifically to PTB domain function, while the phosphorylation sites of the CH1 domain 
are dispensable(Hardy et al., 2007). Shc also participates in shear signaling, and has a known role in 
inflammatory shear stress pathways, including activation of NF-B and expression of ICAM-1 and 
VCAM-1(Liu et al., 2008). Shc also associates with VE-Cadherin after treatment with VEGF or 
induction of shear stress(Liu et al., 2008; Zanetti, 2002). Crucially, the onset of shear stress induces 
transient Shc phosphorylation, which remains high in areas of the vasculature that experience 
disturbed flow(Liu et al., 2008). Shc is also known to participate in angiogenesis, where it is 
instrumental in growth factor and survival signaling(Sweet et al., 2012). Furthermore, endothelial Shc 
is required for arteriogenesis(Sweet et al., 2013). After FAL, endothelial Shc knockout display blunted 
arteriogenesis due to an impaired inflammatory response, characterized by a failure to activate NF-
B, recruit leukocytes, or activate Notch signaling in collateral endothelium(Sweet et al., 2013).  
 This chapter details studies undertaken to understand the role of Shc in vascular 
inflammation culminating in arteriogenesis or atherosclerosis. First, FAL studies are performed with 
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Shc phosphorylation-null mice to test the role of Shc tyrosine phosphorylation in arteriogenesis. 
Second, atherogenic endothelial Shc knockout mice are used to determine the whether Shc is 
required for shear-induced atherosclerotic plaque formation. High fat diet and CAL studies are used 
to determine whether Shc is required for plaque formation.  
 
RESULTS 
Endothelial Shc phosphorylation is required for perfusion recovery after hindlimb ischemia 
Mice containing a mutant p52Shc allele carrying tyrosine to phenylalanine (Y-F) mutations at 
amino acids 239, 240, and 317 were generated previously (L. Zhang et al., 2002) (Figure 3.1A). 
When expressed, this construct represses endogenous Shc signaling through a dominant negative 
mechanism(Plyte et al., 2000; Pratt et al., 1999; Ravichandran, 2001). These animals were crossed 
to Tie2-Cre mice, resulting in endothelial-specific expression of the Shc3F construct. Expression of 
the Shc3F construct was detectable by flag staining in the endothelium of Shc3F;Tie2-Cre, but not 
Shc3F, mice (Fig 3.1B). To determine whether Shc phosphorylation is required for reperfusion after 
femoral artery ligation (FAL), we subjected Shc3F and Shc3F;Tie2-Cre mice to femoral artery ligation, 
followed by measurement of plantar perfusion by Laser Doppler scanning over the course of 3 weeks 
post-surgery (Figure 3.2A). Recovery in Shc3F mice was maximal at 21d post-injury, reaching an 
average of 80% reperfusion in the ligated paw, as compared to the unligated paw. In contrast, 
recovery was impaired in Shc3F;Tie2-Cre mice, plateauing at 50% reperfusion in the ligated paw 3 
weeks post-surgery (Figure 3.2B). Importantly, immediately post-surgery, perfusion values in the 
ligated paws were similar between Shc3F and Shc3F;Tie2-Cre mice, suggesting that the observed 
reperfusion derives entirely from collateral growth after induction of ischemia, and not a basal 
difference in collateral size or number. These results indicate that endothelial Shc phosphorylation is 
required for reperfusion after FAL.  
 
Endothelial, not hematopoietic, Shc phosphorylation is required for reperfusion after FAL 
When used as a promoter for Cre expression, Tie2 drives excision in ECs and a large portion of 
hematopoietic lineages(Constien et al., 2001; Kisanuki et al., 2001; Tang et al., 2010). To disentangle 
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the role of endothelial versus hematopoietic Shc phosphorylation, Shc3F mice were crossed with 
Cadherin5 (Cdh5)-CreERT2 mice, generating a tamoxifen-inducible, endothelial specific Shc3F 
expressing mouse line. Use of this mouse removes any possibility of hematopoietic Cre-mediated 
excision, because Cdh5 promoter activity only occurs in ECs in adult mice. Thus, the Shc3F construct 
is expressed solely in ECs.  
After corn oil or tamoxifen treatment, Shc 3F;Cdh5-CreERT2 mice were subjected to FAL. 
Similar to Shc3F and Shc3F;Tie2-Cre mice, Shc3F;Cdh5-CreERT2 mice experience almost complete 
loss of plantar perfusion in the ligated paw post-surgery (Figure 3.3A). By 7d post-surgery, both corn 
oil and tamoxifen treated mice displayed 25% recovery. However, at 14d and 21d post-surgery, the 
control mice exhibit significantly increased plantar perfusion in the ligated paw. Reperfusion reaches 
maximal levels in control mice at 55%, compared to 35% for tamoxifen treated mice (Figure 3.3B). 
These results demonstrate that endothelial, not hematopoietic, Shc phosphorylation is required for 
reperfusion after hindlimb ischemia.  
 
Shc phosphorylation is required for collateral remodeling after FAL 
Hindpaw reperfusion post FAL is mediated by outward remodeling of collateral vessels in the 
gracilis muscle of the leg(Schaper and Scholz, 2003). To determine whether growth of these vessels 
was impaired in Shc3F;Tie2-Cre mice, morphometry was performed in Hematoxylin and Eosin (H&E) 
stained collateral vessels from Shc3f and Shc3F;Tie2-Cre mice after 21d of recovery from FAL. The 
lumen area before surgery is similar in both genotypes and increases approximately 2.5-fold in 
control mice after FAL (Figure 3.4 A and B). In contrast, collateral growth in Shc3F;Tie2-Cre mice is 
blunted, increasing by 1.5-fold. These results demonstrate that endothelial Shc phosphorylation is 
required for collateral growth after FAL, providing a mechanistic link between blockade of Shc 
phosphorylation and reduction in perfusion recovery.  
 
Shc is required for atherosclerotic plaque formation 
Given the requirement for Shc in physiological vessel growth(Sweet et al., 2012), 
remodeling(Sweet et al., 2013), and shear-induced endothelial inflammation(Liu et al., 2008), we 
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hypothesized that Shc is required for the development of atherosclerosis in mice. To test this 
hypothesis, Shc fl/fl;ApoE-/-;Tie2-Cre mice were generated, resulting in an atheroprone endothelial-
specific Shc knockout. To determine whether Shc is required for atherogenesis, Shc fl/fl;ApoE-/- and 
Shc fl/fl;ApoE-/-;Tie2-Cre mice were fed high fat diet (HFD) for 8 weeks, followed by perfusion 
fixation, removal of the aorta, and plaque visualization using Oil Red O (ORO) staining. ORO staining 
in control aortas revealed a heavy plaque burden in the aortic arch (Figure 3.5A). The largest 
concentrations of plaque occurred at branch points in the greater curvature of the arch, and 
throughout the endothelium of the lesser curvature of the arch. Sporadic plaque formation was seen 
in the descending aorta. In the Shcfl/fl;ApoE-/-;Tie2-Cre mice, overall plaque burden was reduced in 
the arch, while very little reduction was observed in the descending aorta. Plaque area was then 
calculated and quantified as part of the whole aorta, aortic arch, or descending aorta (Figure 3.5B). 
Overall plaque burden was significantly higher in control mice than in Shcfl/fl;ApoE-/-;Tie2-Cre mice, 
with approximately 4% plaque coverage in the whole aorta, versus 1.5% coverage in the 
Shcfl/fl;ApoE-/-;Tie2-Cre mice. The largest difference was observed in the aortic arch, where control 
mice exhibited 10.5% plaque coverage, versus 4% coverage in Shcfl/fl;ApoE-/-;Tie2-Cre mice. No 
difference was observed in the descending aorta. Overall, these results demonstrate a requirement 
for Shc in atheroma formation, suggesting a further role for Shc in shear-induced EC signaling.  
 
Endothelial Shc is required for acute plaque formation after partical carotid artery ligation 
The aorta studies establish a role for Shc in atheroma formation. However, no distinction is 
made between a requirement for Shc in atherogenic shear stress responses and other EC 
inflammatory signaling pathways. To test the requirement for endothelial Shc in atherogenic 
endothelial mechanosignaling, partial carotid artery ligation (CAL), a model of acutely induced 
disturbed flow, was utilized. Control and Tie2-Cre mice were subjected to CAL, followed by HFD 
feeding for 4 weeks. After the feeding period, the carotid arteries were removed and the plaques 
burden was visualized by ORO staining. ORO staining revealed large, complex plaques in control 
mice, while plaques in Tie2-Cre mice were smaller and less complex (Figure 3.6A). Additionally, 
plaque burden in control mice was 77% of lumen area, while plaques covered 48% of lumen area in 
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Tie2-Cre mice (Figure 3.6B). These results suggest that endothelial Shc is required for shear-induced 
plaque formation in carotid arteries.  
 
DISCUSSION 
Inflammatory signaling is critical for the progression of physiological and pathological 
vascular remodeling. Physiologically, collateral arterioles increase in size in response to major vessel 
occlusion(Schaper, 2009). This increase results from shear-induced endothelial inflammation, which 
begins a program of leukocyte recruitment, smooth muscle proliferation, and size increase of 
collateral vessels(Z. Chen et al., 2010; Schaper, 2009; Sweet et al., 2013). In a pathological situation 
such as in atherosclerosis, shear-induced inflammation primes the endothelium for plaque formation 
by promoting lipid uptake, oxidative stress, and inflammatory gene expression(Chatzizisis et al., 
2007; Hahn and Schwartz, 2009). 
Previous work demonstrates the importance of Shc in endothelial inflammation(Liu et al., 
2008; Sweet et al., 2013) and collateral remodeling(Sweet et al., 2013). Using two models of 
inflammatory vascular remodeling, this study further defines the role of Shc in vascular remodeling 
and disease. By blunting endothelial Shc phosphorylation using Shc3F;Tie2-Cre mice in a model of 
hindlimb ischemia, we demonstrate a requirement for Shc phosphorylation in collateral remodeling. 
Second, using Shcflox/flox;ApoE-/-;Tie2-Cre mice, which are an atheroprone endothelial Shc 
knockout, we demonstrate a role for Shc in atherosclerosis in the aorta and in ligated carotid arteries.  
Collateral remodeling is a shear-directed process. Collateral vessels normally experience no 
net blood flow, but after nutritive vessel occlusion, a major increase in blood flow and shear stress 
occurs(Eitenmuller, 2006; Schaper and Scholz, 2003). This acute change in shear causes an 
increase in endothelial proliferation and NF-B activation, both of which require Shc(Sweet et al., 
2013). Crucially, Shc is highly phosphorylated in collateral vessels within 24 hours of nutritive vessel 
occlusion(Sweet et al., 2013). Thus we hypothesized that phosphorylated Shc plays a crucial role in 
the endothelial shear stress response, and therefore collateral remodeling. To this end, we used Shc 
phosphorylation-null mice in a model of hindlimb ischemia to determine whether Shc phosphorylation 
is required for arteriogenesis. Our results show that 21 days after FAL, our phosphorylation-null mice 
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exhibited significantly lower plantar perfusion in the ligated paw, compared to control mice. 
Additionally, we observed smaller collaterals in Shc3F;Tie2-Cre mice after 21 days of FAL. Though 
the mechanisms at work remain unclear, these data suggest a role for Shc tyrosine phosphorylation 
in recovery from FAL. Outstanding questions remain about the role of Shc phosphorylation in 
arteriogenesis. Specifically, is Shc phosphorylation required for the host of signaling that leads to 
vessel growth, such as endothelial inflammation, endothelial proliferation, and leukocyte recruitment? 
These processes are all abrogated when endothelial Shc is knocked out(Sweet et al., 2013), but 
whether they specifically require Shc phosphorylation remains unknown.  
This study also addresses the role of Shc in the progression of atherosclerosis. While Shc is 
known to be required for endothelial inflammation in vitro(Liu et al., 2008) and arteriogenesis in 
vivo(Sweet et al., 2013), its involvement in a chronic inflammatory condition such as atherosclerosis 
has not been tested. Using Shc fl/fl;ApoE-/-;Tie2-Cre mice, this study establishes a requirement for 
Shc in atherosclerosis. Specifically, we show that the incidence of atherosclerosis in the aortic arch, 
an area of the aorta that experiences disturbed flow, sharply decreases in Shc fl/fl;ApoE-/-;Tie2-Cre 
mice. Additionally, we demonstrate that atherogenesis is blunted in Shc fl/fl;ApoE-/-;Tie2-Cre mice 
after acute application of disturbed shear stress using CAL. Taken together, these data demonstrate 
that endothelial Shc is required atherogenesis, and that Shc is a major component of the disturbed 
shear-responsive signaling pathway that gives rise to atherosclerosis.  
While these data suggest a role for Shc in plaque formation, the underlying mechanisms remain 
unknown. Atherosclerosis occurs as cholesterol and immune cells accumulate under the 
endothelium, processes which both rely on high endothelial inflammation and permeability(Chatzizisis 
et al., 2007). Given its known role in endothelial inflammation(Liu et al., 2008), the observed reduction 
in plaque size may be a result of reduced endothelial inflammation. Additionally, cell spreading and 
focal adhesion arrangement are aberrant in Shc knockout ECs(K. M. Lai and Pawson, 2000), raising 
the possibility that Shc may also regulate endothelial permeability through regulation of the actin 
cytoskeleton. Furthermore, p66Shc is a known regulator of reactive oxygen species (ROS) 
generation(Migliaccio et al., 1999) and is phosphorylated in response to oxidized low density 
lipoprotein (oxLDL) treatment(Y. Shi et al., 2014). p66Shc also promotes atherosclerosis(Martin-
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Padura et al., 2008), raising the possibility that knockout of all ShcA isoforms may repress 
mechanical and biochemical signaling pathways which promote atherosclerosis. 
 
MATERIALS AND METHODS 
Mouse Lines Shc floxed and Shc3F mice were a kind gift from Kodi Ravichandran of the University 
of Virginia (L. Zhang et al., 2002). ApoE-/- mice were a kind gift from Nobuyo Maeda of the Univeristy 
of North Carolina- Chapel Hill(S. H. Zhang et al., 1992). Cdh5-CreERT2 mice were a kind gift from 
Ralph Adams of The Max Planck Institute for Biomedicine (formerly of Cancer Research UK). Tie2-
Cre mice were purchased from Jackson Labs. All housing, breeding, and experimental procedures 
were done in accordance with national guidelines, and were approved by the Institutional Animal 
Care and Use Committee at the University of North Carolina- Chapel Hill. For FAL experiments, 
Shc3F, Shc3F;Tie2-Cre, and Shc3F;Cdh5-CreERT2 age-matched littermates were used between the 
ages of 10 and 14 weeks. For long-term HFD studies, Shcfl/fl;ApoE-/- and Shcfl/fl;ApoE-/-;Tie2-Cre 
age-matched littermates were used at 8 weeks of age. For CAL experiments, Shcfl/fl;ApoE-/- and 
Shcfl/fl;ApoE-/-;Tie2-Cre age-matched littermates were used at 8 weeks of age. Genotyping was 
performed by toe clip on neonatal pups. Analysis was carried out by observers blind to genotype.  
Femoral Artery Ligation Surgery The surgical procedure was described previously (REF). Animals 
were anesthetized with 1.125% isofluorane mixed with oxygen. While under anesthesia, body 
temperature was maintained by a 37 heating pad. Before the incision, hair was removed from the 
hindquarters with a depilating cream. Using aseptic technique, the femoral artery was then exposed 
through a 2mm incision. After isolation from the vein and nerve, the femoral artery was ligated with 7-
0 sutures proximal to the bifurcation of the popliteal artery and distal to the lateral caudal femoral 
artery. The artery was then severed between the sutures to further prevent blood flow. After irrigation 
of the wound with sterile saline, the incision was closed and the mouse was allowed to recover in a 
large, warmed chamber.  
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Laser-Doppler Imaging Mice were anesthetized using 1.5% isoflurane, and maintained at this level 
for the duration of scanning. After initial anesthesia, the mouse was transferred to a 37 heat block to 
maintain body temperature. 1.5% isoflurane was continuously supplied via a nosecone. The core 
temperature of the mouse was maintained between 36.5 and 37.5 to ensure consistent vascular 
tone between mice. The paws of the mouse were gently taped flat to the heating block to ensure 
identical positioning, and a Laser-Doppler imager (Perimed PeriScan PIM3) was used to measure 
relative blood flow. Values from ligated and unligated paws were obtained before and immediately 
after surgery, 24h, 3d, 5d, 7d, 14d, and 21d post-surgery. Plantar perfusion was determined within 
anatomically defined regions of interest (ROIs), which were drawn by an investigator blind to 
genotype.  
Collateral Vessel Morphometry To harvest collateral vessels, animals were transcardially perfused 
with PBS containing 10nmol/L sodium nitroprusside and 10U/ml heparin after 3 weeks of hindlimb 
ischemia. After PBS perfusion, 2% paraformaldehyde was perfused for 20 minutes. The anterior and 
posterior gracilis muscles were then harvested and fixed for 16 hours in 2% PFA. A 5mm section was 
trimmed from the center of the gracilis muscle and embedded in paraffin. This was then sectioned 
into 5m sections and stained with H&E. These H&E stained cross-sections were then imaged at 60x 
magnification on an Olympus IX-81 microscope. The circumference of the lumen was then traced 
using NIH ImageJ. At least 3 collaterals were measured from the ligated and unligated muscles, and 
then an average lumen area was computed for each animal. Morphometry was performed by an 
investigator blinded to mouse genotype.  
Tamoxifen Administration Sterile 20mg/ml Tamoxifen (Sigma Aldrich, T5648-1G) and corn oil were 
prepared and stored at -20 until use. Mice received 2mg/kg tamoxifen or an equivalent amount of 
corn oil via intraperitoneal injection once daily for three days. Mice were used one week after the 
cessation of tamoxifen administration to allow for induction of Cre-mediated recombination.  
Partial Carotid Artery Ligation Partial carotid artery ligation was performed as described 
previously(Z. Chen and Tzima, 2009; Nam et al., 2009). Briefly, Shcfl/fl;ApoE-/- or Shcfl/fl;ApoE-/-
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;Tie2-Cre mice were anesthetized using 1.5% isoflurane. Hair around surgery area was removed 
using a depilating cream. Using sterile technique, a 2mm incision was made into the neck and the left 
external, occipital, and internal carotid arteries were isolated and ligated using 7-0 sutures. The 
thyroid artery was left unligated, which maintained approximately 10% blood flow through the ligated 
carotid artery. The wound was then closed, and buprenorphine was administered as an analgesic.  
High Fat Diet Studies For long term high fat diet studies, 8-week old Shc fl/fl;ApoE-/- and Shc 
fl/fl;ApoE-/-;Tie2-Cre mice were fed high fat diet (Harlan Teklad TD.88137, 42% of calories from fat, 
0.2% cholesterol) ad libidum for 8 weeks, following dissection of the aorta and collection of blood for 
lipid profiling. For CAL studies, 8-week old Shc fl/fl;ApoE-/- and Shc fl/fl;ApoE-/-;Tie2-Cre mice were 
fed HFD ad libidum for 4 weeks, before fixation and removal of carotid arteries.  
Plaque Area Quantification Aortic measurements: After high fat diet feeding, aortas were removed 
from mice, stained with ORO, and mounted en face in black wax for imaging. Images were obtained 
using a handheld digital camera. Aortic plaque burden was determined by tracing plaques and 
measuring their surface area using NIH ImageJ software. Total aortic area was determined in the 
same manner. To measure total plaque burden, the total plaque area was divided by total aortic area. 
For site-specific plaque burden measurements, the aorta was divided into the arch region and 
descending regions. The first intercostal branch was used as the beginning of the descending region. 
Carotid artery measurements: Measurements were performed as previously reported(Nam et al., 
2009). Briefly, after surgery and high fat diet feeding, carotid arteries were perfusion fixed and 
removed from mice, followed by cryopreservation on 30% sucrose for 16h. After cryopreservation, the 
carotids were embedded in OCT and sectioned. Sections from within 2mm of the apex of the carotid 
ligation were taken and stained with Oil Red O and Hematoxylin. Using NIH ImageJ software, the 
circumferences of the internal elastic lamina (IEL) and lumen were measured. Values were expressed 
as percent of total lumen area filled with plaque. Plaque area was calculated by subtraction of lumen 
area from the area within the IEL, and percent plaque area was calculated by dividing plaque area by 
the total area inside the IEL.  
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Figure 3.1 The Shc phospho-null mutant construct 
 
 
 
(A) Depiction of the Shc phospho-null mutant construct. The central aspect of the construct is a 
FLAG-tagged ShcA allele with Tyr239/240 and 317 mutated to Phe, rendering the end product 
phospho-null. The construct co-expresses GFP via an internal ribosomal entry site, and is driven by 
the human EF1α promoter. A floxed stop sequence intervenes between the promoter and coding 
region. When Shc3F mice express Tie2-Cre, the stop sequence is excised and the Shc3F construct is 
expressed. (B) Immunofluorescence for FLAG shows robust staining in the endothelium of 
Shc3F;Tie2-Cre mice, but not Shc3F mice.  
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Figure 3.2 Shc tyrosine phosphorylation is required for plantar reperfusion after FAL 
 
 
(A) Plantar reperfusion is blunted in Shc3F;Tie2-Cre mice as compared to Shc3F littermates. 
Representative Laser Doppler images from Shc3F and Shc3F;Tie2-Cre mice before (Pre), 
immediately after (Acute), 7 days after, and 3 weeks after femoral artery ligation. The images are 
pseudocolored: Black = 0 and bright red = 1000 arbitrary units. (B) Ratio of plantar perfusion (ligated 
versus sham paw), as quantified from the Laser Doppler image. The graph represents the mean 
reperfusion ± SEM. * = p<0.05; ** = p<0.01. n=11 Shc 3F and 10 Shc 3F/Tie2-Cre mice.  
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Figure 3.3 Endothelial, not hematopoietic, Shc is required for plantar reperfusion after FAL 
 
 
(A) Plantar reperfusion is blunted in Shc3F;Cdh5-CreERT2 mice treated with Tamoxifen as compared 
to Corn Oil-treated littermates. Representative Laser Doppler images from Corn Oil- and Tamoxifen-
treated Shc3F;Cdh5-CreERT2 mice before (Pre), immediately after (Acute), 7 days after, and 3 
weeks after femoral artery ligation. The images are pseudocolored: Black = 0 and bright red = 1000 
arbitrary units. (B) Ratio of plantar perfusion (ligated versus sham paw), as quantified from the Laser 
Doppler image. The graph represents the mean reperfusion ± SEM. * = p<0.05. n= 8 Corn Oil and 9 
tamoxifen treated mice.  
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Figure 3.4 Shc tyrosine phosphorylation is required for collateral remodeling in response to 
FAL 
 
 
(A) Blunted arteriogenesis in Shc3F;Tie2-Cre mice. The gracilis muscle was harvested from Shc3F 
and Shc3F;Tie2-Cre mice 21d after FAL surgery. The muscle was sectioned and stained with H&E, 
and collateral circumference was measured. 2 collaterals per condition per mouse were measured. 
(B) Lumen area was calculated from the collateral measurements. Sham: n= 6 Shc 3F and 5 Shc 
3F/Tie2-Cre mice; Ligated: n= 5 Shc 3F and 4 Shc 3F/Tie2-Cre mice.  
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Figure 3.5 Endothelial Shc is required for atherogenesis 
 
(A) Shc fl/fl and Shc fl/fl;Tie2-Cre mice were fed high fat diet for 8 weeks, followed by isolation of the 
aorta and ORO staining. Aortas were mounted whole and imaged with a digital camera. (B) Plaque 
area was quantified. All plaques were measured, and then subdivided based on location in the aorta. 
The perimeter of the whole aorta was used for % surface area measurements. Horizonal black bars 
represent the mean. n = 5 Shc fl/fl and 4 Shc fl/fl;Tie2-Cre mice.   
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Figure 3.6 Endothelial Shc is required for atherogenesis in response to altered hemodynamics 
 
(A) Shc fl/fl and Shc fl/fl;Tie2-Cre mice were subjected to CAL surgery, followed by high fat diet 
feeding for 4 weeks. After 4 weeks of recovery, the carotid arteries were harvested, sectioned, and 
stained with ORO. (B) Plaque area was quantified. n= 3 Shc 3F and 6 Shc 3F/Tie2-Cre mice.  
 
  
 
 
83 
 
 
Chapter 4 Discussion and Future Perspectives 
 
 
OVERVIEW 
It is well established that PECAM-1 is an endothelial mechanosensor that is required for 
inflammatory and anti-inflammatory endothelial phenotypes(Tzima et al., 2005). PECAM-1-dependent 
mechanosignaling presents a quandary for vascular biologists. It is at once beneficial and detrimental 
to vascular health(Goel et al., 2008; Harrison et al., 2013b; Harry et al., 2008; Stevens et al., 2008); a 
critical player in endothelial mechanosignaling that is seemingly dispensable for development, as 
PECAM-1 null mice are born healthy and at normal Mendelian ratios(Duncan et al., 1999; Tzima et 
al., 2005). However, PECAM-1 plays a critical role in processes such as vascular remodeling(Z. Chen 
and Tzima, 2009), arteriogenesis(Z. Chen et al., 2010), and atherosclerosis(Harry et al., 2008). 
Therefore, understanding the signaling pathways downstream of PECAM-1 activation is critically 
important for understanding the biology of PECAM-1 and designing vascular therapeutics based in 
endothelial mechanosignaling. This thesis provides mechanistic insights into how initiation of 
PECAM-1 signaling can lead to regulation of vascular phenotypes. Specifically, Chapter II of this 
thesis describes a mechanism by which PECAM-1 regulates FN assembly through EC-generated 
tension and integrin binding. As FN is known to be a pro-inflammatory stimulus(Feaver et al., 2010; 
Orr et al., 2005) for ECs and a scaffold for assembly of other ECM molecules, Chapter II identifies a 
mechanism by which shear stress may regulate endothelial inflammation through assembly of FN 
fibrils. Additionally, Chapter III presents data which describe a role for the adaptor protein Shc, a 
mechanotransducer activated downstream of PECAM-1/VE-Cadherin/VEGFR2 mechanosignaling(Liu 
et al., 2008), in vascular inflammation. My data suggest that Shc tyrosine phosphorylation is required 
for arteriogenesis, and that Shc is required for the formation of atherosclerotic plaques. These results 
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suggest that Shc may regulate inflammation in ECs, providing a potent target for vascular 
therapeutics for pathologies arising from aberrant endothelial mechanosignaling. Taken as a whole, 
these data provide novel insights into the mechanisms of endothelial mechanosignaling, but also 
open up many unanswered questions. These questions are discussed in further detail below.  
 
CHAPTER 2: HAEMODYNAMICS REGULATE FIBRONECTIN ASSEMBLY VIA PECAM 
 The aim of this chapter was to determine whether PECAM-1 regulates FN assembly in 
response to hemodynamics. To that end, we subjected PECAM-1 null mice to CAL surgery and 
utilized PECAM-1 KO cells to determine how PECAM-1 might regulate FN assembly. This study 
found that PECAM-1 is required for FN assembly in areas of laminar and disturbed flow, and that FN 
assembly requires cell contractility regulated by integrin binding and RhoA. Additionally, we found that 
expression of FN is dramatically reduced in KO cells and that when exogenous FN was provided to 
KO cells, the cells were unable to assemble FN into fibrils. This suggests that PECAM-1 is required 
for cellular contractility that induces FN fibrillogenesis. 
 
Hemodynamic Regulation of FN Assembly 
 A novel insight in this body of work is that PECAM-1 is required for FN fibrillogenesis. This is 
the first time that the specific mechanism linking hemodynamics and FN assembly has been 
delineated, though previous studies suggested a link between hemodynamics and FN. Evolutionarily, 
FN is thought to have arisen with the vasculature(Hynes, 2007), which suggests close involvement of 
FN with vascular function, including the possibility of FN interacting with the physical forces that 
impinge on the endothelium. Additionally, early work examining ECM assembly in the abdominal 
aorta revealed that in areas of laminar flow, FN fibrils align in the direction of flow, while in areas of 
disturbed flow, these fibrils exhibit a random pattern of alignment(Jinguji and Fujiwara, 1994). 
Furthermore, it has been shown PECAM-1, a well-known mechanosensor(Tzima et al., 2005), 
regulates FN expression(Feaver et al., 2010). 
 Neointima formation in PECAM-1-/- mice is blunted when these mice are subjected to CAL. 
This reduction in neointima formation is a result of impaired NF-κB signaling, a hallmark of vascular 
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inflammation(Z. Chen and Tzima, 2009). FN is required for both short term(Liu et al., 2008; Orr et al., 
2005) and long term(Chiang et al., 2009b) inflammatory phenotypes in the vasculature, and 
assembled FN is required for shear-induced endothelial inflammation(Chiang et al., 2009a). 
Additionally, deposition of FN induces a positive feedback loop that sustains endothelial 
inflammation(Feaver et al., 2010). Therefore it is tempting to speculate that regulation of FN assembly 
and expression by PECAM-1 modulates endothelial phenotype via control of initiation and 
continuation of endothelial inflammation. If FN assembly is blocked, endothelial inflammation and 
attendant FN expression do not occur, and therefore cannot sustain chronic inflammation in the 
presence of altered hemodynamics. This potentially has profound consequences for vascular 
physiology, including alterations in endothelial permeability and inflammation, and pathologies such 
as atherosclerosis.  
  
FN Assembly and EC Permeability 
 In ECs, FN induces several matrix-specific signaling events that are associated with vascular 
pathologies like atherosclerosis. ECs exhibit specific inflammatory and anti-inflammatory phenotypes; 
FN may be part of the switch between anti-inflammation and inflammation. Though ECs normally 
reside on basement membrane consisting of Collagen (CL) and Laminin (LM), FN is deposited in 
response to inflammatory insults like disturbed flow(Feaver et al., 2010; Orr et al., 2005). The 
deposition of FN helps initiate and sustain inflammatory EC phenotypes(Feaver et al., 2010). FN 
deposition also increases endothelial permeability, a process that is regulated by p21-activated 
kinase (PAK)(Orr et al., 2007). Importantly, the increase in endothelial permeability is specific to FN 
matrix and does not occur on CL(Orr et al., 2007). Matrix-specific regulation of PAK activity by protein 
kinase A (PKA) also occurs. Basement membrane promotes PKA activation and concomitant PAK 
repression, while FN matrix promotes PAK activation through repression of PKA(Funk et al., 2010). 
Taken together, these results introduce a major feature of FN deposition and assembly—FN is 
necessary for induction of inflammatory endothelial phenotypes, and its expression can have major 
consequences for vessel health. For example, increases in endothelial permeability are associated 
with atherogenic phenotypes and with areas of disturbed flow in the vasculature(Himburg et al., 
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2004). Sites of disturbed flow are also associated with increased LDL accumulation(HERRMANN et 
al., 1994; Sakellarios et al., 2013). Therefore, it is tempting to hypothesize that reduced FN 
expression and assembly in PECAM-1-/- mice serves as an atheroprotective mechanism, and works 
through modulation of junctional integrity in the endothelium.  
 
FN Assembly and Vessel Stiffness 
 PECAM-1 is also known to regulate eNOS signaling; in PECAM-1-/- cells, eNOS activation is 
misregulated(McCormick et al., 2011). This may have consequences for FN assembly and matrix 
stiffness, as eNOS activity represses the activity of tissue transglutaminase (tTG), a critical 
crosslinker of ECM proteins. Repression is achieved through production of NO species, which lead to 
S-nitrosylation (SNO) of tTG, thus preventing its extracellular crosslinking function(T. S. Lai et al., 
2001). Critically, tTG activity enhances, but is not sufficient for, FN assembly which is completely 
blocked through inhibition of α5β1 integrins(Akimov and Belkin, 2001; L. Yuan et al., 2007). 
Overactivation of tTG has also been implicated in the vascular processes of vascular remodeling and 
age-related vascular stiffening. In porcine carotid arteries cultured in vitro, tTG activity was required 
for the lumen narrowing that is characteristic of vascular remodeling(Bakker et al., 2005). Importantly, 
stimulation of tTG expression increased the narrowing of the artery lumen, while inhibiting tTG 
function using cadaverine completely blocked lumen narrowing(Bakker et al., 2005). Similar results 
were found in a study examining age-related stiffening in rat arteries. tTG-null mice show impaired 
matrix crosslinking, and do not stiffen their arteries in response to eNOS inhibition, which removes 
blockade of tTG activation in mice(Santhanam et al., 2010). Matrix crosslinking also increased with 
age in WT mice, while tTG expression did not. A reduction in age-related matrix crosslinking was 
observed when tTG was inhibited(Santhanam et al., 2010). Additionally, tTG activity increases in 
eNOS null mice, leading to increased matrix crosslinks and stiffer vessels in the absence of a major 
repressor of tTG(S. M. Jung et al., 2013). These data suggest that the endothelial dysfunction that 
attends age may remove barriers to vessel stiffening.  
Given that PECAM-1 knockout leads to abberant eNOS activation, it is tempting to 
hypothesize that PECAM-1-/- mice inappropriately repress tTG function, therefore leading to further 
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deficits in FN assembly. Data supporting this hypothesis are slim, however I performed 
immunofluorescence studies for SNO levels in PECAM-1-/- and WT carotid arteries after the mice 
were subjected to carotid artery ligation. 24h after ligation, WT mice show an approximately 1.5-fold 
increase in SNO in ECs, which returns to baseline by 5 days post-ligation. The PECAM-1-/-  mice, 
however, show an approximately 2.5-fold increase in SNO through 3 weeks of recovery post-ligation. 
These data suggest that a defect in matrix crosslinking may augment the observed defect in FN 
assembly. However, more work is needed to delineate the mechanism.  
Does PECAM-1 regulate age-related vascular stiffening? If the relationship between PECAM-
1 and tTG is supported by more data, it may provide a robust link between hemodynamics and age-
related vascular stiffening. This would be an important discovery, as vascular stiffness is a potent 
contributor to devastating vascular pathologies such as atherosclerosis, hypertension, and aortic 
dissection. It has been shown that PECAM-1 regulates endothelial stiffness in a matrix-specific 
manner, as ECs stiffen in response to direct force on PECAM-1 on FN but not CL(Collins et al., 2014; 
2012). Additionally, matrix selectivity in EC stiffness translates in vivo. Using passive microbead 
rheology, it was shown that ECs are stiffer in areas of higher FN content, namely the aortic arch, 
versus areas of higher CL content like the descending aorta. (Collins et al., 2014). A similar technique 
could be used on aortas from PECAM-1-/- mice in order to determine the relative stiffness of ECs in 
areas of higher FN. Though the relationship between endothelial stiffness and matrix stiffness is 
unclear, it is reasonable to speculate that endothelial stiffness may reflect matrix stiffness. Endothelial 
stiffness arises as a result of highly activated RhoA, the same pathway that is highly activated in ECs 
when cultured on stiff substrates(Collins et al., 2012; Huynh et al., 2011). Understanding the 
relationship between hemodynamics, endothelial mechanosensing, and vascular stiffness is an 
important challenge moving forward. As the mechanisms of shear sensing become more well 
understood, it is important that findings from studies of shear stress be integrated with studies of 
other mechanical functions of vessels. This will allow a more holistic view of the vessel to emerge, 
where mechanical and biological factors are studied together in order to understand physiology and 
better design therapeutics for vascular disease.   
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CHAPTER 3: THE ADAPTOR PROTEIN SHC IS A MAJOR REGULATOR  
OF ENDOTHELIAL INFLAMMATION 
 The aim of this chapter was to determine the specific role of endothelial Shc in acute and 
chronic vascular inflammatory remodeling. I tested the role of Shc tyrosine phosphorylation in 
arteriogenesis, which is the outward remodeling of collateral arteries, and found blunted 
arteriogenesis in Shc phosphorylation-null mice. Additionally, I tested the role of Shc protein in the 
formation of atherosclerotic plaques, finding a significant reduction in plaque burden in endothelial 
Shc-null mice. These results demonstrate a central role for Shc, and specifically Shc tyrosine 
phosphorylation, in inflammatory remodeling in the vasculature. However, the present study raises 
many important questions, which are discussed below.  
 
The role of Shc tyrosine phosphorylation in endothelial inflammation and atherogenesis 
 The work presented in Chapter III utilize a knock-in mouse that expresses a Shc 
phosphorylation-null mutant (Shc3F) protein after Cre recombinase-mediated excision of a stop 
cassette. In Chapter III, these mice were used to test the requirement of Shc phosphorylation in 
arteriogenesis. My data show a requirement for Shc tyrosine phosphorylation in arteriogenesis, and 
acute inflammatory condition of the vasculature(Schaper, 2009).  
In murine arteriogenesis, vessel inflammation subsides after flow is normalized, a period of 
time lasting two to three weeks(Sweet et al., 2013). Shc phosphorylation occurs briefly at the outset 
of arteriogenesis, in agreement with in vitro studies of ECs exposed to laminar shear stress showing 
transient Shc phosphorylation at early shear time points(Liu et al., 2008; Sweet et al., 2013). 
Interestingly, Shc phosphorylation is not always transient. In areas of the vasculature that normally 
experience disturbed flow, such as the lesser curvature of the aortic arch or the fibrous cap of an 
atherosclerotic plaque, Shc phosphorylation remains high(Liu et al., 2008). This difference in Shc 
phosphorylation between areas of different flow regimes raises the possibility that Shc 
phosphorylation acts as a switch between inflammatory and anti-inflammatory signaling pathways in 
ECs. In such a system, Shc would induce inflammatory flow patterns downstream of disturbed flow, 
ceasing such induction after the normalization of inflammatory flow. Thus, if disturbed flow is chronic, 
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then Shc would continue to be activated and endothelial inflammation would persist. If Shc 
phosphorylation is blocked, endothelial inflammation would also be blocked.  
 My results support this model, while underscoring the need for further studies. In the HLI 
model, loss of Shc phosphorylation blunted arteriogenesis. My immunofluorescence data suggest that 
this blunted arteriogenesis was attended by a reduction in NF-κB signaling, demonstrating a role for 
Shc phosphorylation in endothelial inflammation. To extend these findings, the role of Shc 
phosphorylation in arteriogenesis must be delineated further through in vitro and in vivo methods. A 
hallmark of arteriogenesis, macrophage accumulation(Schaper, 2009; Sweet et al., 2013), will be 
assessed around growing collaterals to determine whether loss of Shc phosphorylation leads to loss 
of immune cell recruitment. Additionally, ICAM-1 and VCAM-1, the cell surface proteins intimately 
involved in recruitment of immune cells, expression should be assayed in post-HLI collaterals. Should 
deficits be found in all of these areas in Shc3F;Tie2-Cre mice, it would demonstrate a profound defect 
in the endothelial inflammatory response to shear stress, placing Shc at the center of inflammatory 
signaling. Another in vivo aim is to test the role of Shc phosphorylation in atherogenesis, a chronic 
inflammatory condition where endothelial Shc phosphorylation is also chronically high. Using 
Shc3F;Cdh5-CreERT2;ApoE-/- mice, this line of experimentation is reasonable and would provide 
detailed mechanistic insight into a central regulator of endothelial shear signaling. In this model, if Shc 
phosphorylation is central to the endothelial inflammatory response, atherogenesis will be either 
reduced or completely blocked. These studies are necessary to delineate whether Shc 
phosphorylation is a cause endothelial inflammation, or is simply secondary to chronic disturbed flow. 
While my data and previous studies suggest that Shc phosphorylation is required for atherogenesis, 
the involvement of Shc phosphorylation in atherogenesis must be fully determined. If Shc 
phosphorylation is required for atherogenesis, such a result would provide more evidence that Shc is 
a central regulator of endothelial inflammation. It may also provide a target for future therapeutics. By 
blocking chronic endothelial inflammation, while allowing anti-inflammatory responses to persist in the 
endothelium, shear signaling might be used to combat atherogenesis and other pathological vessel 
remodeling. This also underscores the importance of understanding whether Shc is required for anti-
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inflammatory shear signaling in ECs. If Shc does not regulate anti-inflammatory signaling, it may truly 
represent a switch between inflammatory and anti-inflammatory signaling in ECs.  
 Lastly, the role of p66Shc must be taken into account in vascular dysfunction. p66Shc is the 
largest isoform of ShcA, and is notably different because of the presence of its long N-terminal tail 
that contains a phosphorylation site, Serine 36(Wills and Jones, 2012). In response to oxidant stress, 
Serine 36 is phosphorylated by Protein Kinase C β (PKCβ), and localizes to the mitochondrial 
membrane under the guidance of Prolyl Isomerase 1 (Pin1)(Pinton et al., 2007). Once recruited to the 
mitochondria, p66Shc then stimulates apoptosis via interaction with cytochrome c(Wills and Jones, 
2012). Importantly, p66Shc has a role in vascular disease, where it promotes age-related vascular 
dysfunction and advanced atherosclerosis(Francia et al., 2004; Martin-Padura et al., 2008). In aged 
mice, increased levels of superoxide production and nitrotyrosine species are present in the 
vasculature of WT mice as compared to p66Shc-null mice(Francia et al., 2004). Additionally, 
atherosclerotic plaque growth is reduced in p66Shc-null mice(Martin-Padura et al., 2008). This may 
be partly a result of oxidative stress induced by oxLDL avtivating p66Shc, which leads to uncoupling 
of eNOS signaling(Y. Shi et al., 2014). However, regulation of p66Shc by shear stress signaling 
remains poorly understood. As oxidative stress plays a major role in shear signaling and pathologies 
emanating from shear signaling, p66Shc is a worthwhile avenue of study, and could yield important 
insight into the regulation of endothelial inflammation by Shc.  
  
The role of downstream effectors on Shc signaling 
Shc phosphorylation is important because of its ability to effect multiple downstream signaling 
cascades. In the case of Shc, the best known effector is the adaptor protein Growth Factor Receptor 
Bound Protein 2 (Grb2). When bound to Shc, Grb2 leads to activation of the RasGEF Son-of-
Sevenless (SOS), which potentiates downstream Ras signaling, including mitogen-activated protein 
kinase kinase (MEK) and extracellular signal related kinase (ERK) signaling(Ravichandran, 2001). 
The interaction between Shc and Grb2 has been shown to occur very early, approximately 5 minutes, 
after the onset of shear stress(K. D. Chen et al., 1999), but its overall function in shear signaling has 
not been fully explored. Additionally, Shc associates with integrins after the onset of shear stress, but 
 
 
91 
this association occurs later in shear signaling. Association with αvβ3 integrins occurs at 30 minutes 
after the onset of shear, while association with β1 and β5 integrins occurs after 1 hour of shear(K. D. 
Chen et al., 1999; Liu et al., 2008). In the context of shear, Shc phosphorylation occurs upstream of 
integrins and is VE-Cadherin dependent, as is Shc association with αvβ3 integrins(Liu et al., 2008). 
Shc phosphorylation, however, is independent of matrix composition, further suggesting that Shc is 
phosphorylated upstream of its interaction with integrins(Liu et al., 2008). 
The consequences of the association of Shc with integrins remain to be explored in the 
context of shear signaling, and could be key in understanding the role of Shc phosphorylation in 
endothelial inflammation. EC adhesion to FN induces Shc association with α5β1 integrins(Wary et al., 
1996). This association leads to Shc phosphorylation, recruitment of Grb2, and cell cycle regulation. 
New integrin ligation is a shared attribute of cellular adhesion and shear stress signaling. Many shear 
responses are downstream of integrins, including regulation of RhoA and endothelial alignment in the 
direction of flow, both of which require new integrin ligations to FN(Tzima et al., 2001). Major 
inflammatory signaling, notably NF-κB-dependent transcription, also occurs downstream of integrins. 
This is evidenced by the matrix selectivity of NF-κB activation, which peaks at about 60 minutes after 
the onset of shear—a timescale similar to that of Shc binding to integrins(Liu et al., 2008; Orr et al., 
2005). NF-κB activation is dependent on the small GTPase Rac1, the activation of which is 
dependent on new integrin binding to FN(Tzima et al., 2002). Another modulator of NF-κB activation, 
PAK, is also activated in a matrix-specific manner(Orr et al., 2008). Though shear-induced ROS 
production is matrix independent, PAK modulates this signaling and promotes NF-κB activation 
specifically FN and not CL(Orr et al., 2008). These data, taken together with evidence supporting a 
central role for Shc in regulating endothelial inflammation in vitro and in vivo(Liu et al., 2008; Sweet et 
al., 2013), suggest that Shc may play a major role in inflammatory signaling downstream of integrins. 
Perhaps phosphorylated Shc translocates and binds to integrins, altering the conformation of integrin-
based signaling platforms and allowing NF-κB activation to occur in the process? In this case, Shc 
phosphorylation may not bind partners directly required for signaling downstream of integrins, but 
rather might be required for translocation. It is also possible that Shc may bind as yet undefined 
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partners in response to shear stress; mass spectrometry experiments may help in elucidating novel 
interactors with Shc. 
Lastly, whether Shc regulates the actin cytoskeleton remains an open question. The 
regulation of cytoskeletal function by Shc is an important question, given that important endothelial 
phenotypes, such alignment in the direction of shear and permeability, are chiefly regulated by the 
actin cytoskeleton(Huynh et al., 2011; Tzima et al., 2001). To date, not enough work has been done 
to mechanisticly link Shc function to regulation of cytoskeletal phenotypes, especially in the context of 
shear stress. However, the data that do exist, mostly obtained in systems outside of the endothelium, 
suggest that Shc is involved in force-dependent regulation of the cytoskeleton. Fibroblasts isolated 
from ShcA-null mice display a hypercontractile phenotype, staying round and declining to spread 
when grown in tissue culture(K. M. Lai and Pawson, 2000). Also, since Shc associates with integrins 
after the onset of shear stress, it is possible that it participates in the regulation of cytoskeletal 
elements. In felines, Shc forms an insoluble complex on integrins with FAK after right ventricle 
pressure overload(Laser et al., 2000). A similar result was seen in cardiomyocytes in the presence of 
RGD peptide; Shc, FAK, and other proteins associate in focal complexes at integrins in response to 
stimulation with RGD(Laser et al., 2000). More recently, a study done in HUVECs demonstrated that 
FAK is required for the recruitment of Shc to integrins after the application of tension on integrins with 
FN-coated magnetic beads(Wu et al., 2016). Furthermore, p66Shc was shown to be required for 
activation of p115-RhoGEF and GEF-H1, as well as RhoA activation downstream of force on 
integrins(Wu et al., 2016). These data represent an excellent use of a reductionist system to delineate 
signaling relationships; however, the role of Shc in shear-induced cytoskeletal regulation remains to 
be uncovered.  
The data presented in Chapter III underscore the physiological significance of Shc signaling 
in vascular inflammation. These data demonstrate specific requirements for Shc tyrosine 
phosphorylation in arteriogenesis, and for Shc in atherosclerosis. They also suggest a mechanism by 
which Shc may regulate shear responses based on the stimulus perceived, whether it be laminar or 
disturbed flow. Shear-induced inflammation and vascular remodeling occur as a result of altered 
hemodynamics, whether the insult is acute or chronic. The purpose of inflammatory remodeling is to 
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normalize flow conditions—in the case of arteriogenesis, reduction of shear stress to physiological 
levels is the end result(Schaper, 2009). Arteriogenesis is an example of outward vascular remodeling 
in response to high shear stress(Schaper and Scholz, 2003), where the extent of collateral 
remodeling is governed by the magnitude of shear forces experienced by collateral 
vessels(Eitenmüller et al., 2006; Pipp et al., 2004). Conversely, atherosclerosis is an example of 
pathological inward remodeling, which occurs in response to low and disturbed flow(Dajnowiec and 
Langille, 2007). Chronic disturbed flow initially causes outward remodeling of the vessel, but when 
plaques grow large enough, they eventually begin to block the vessel lumen, and lead to pathologies 
like heart attack, stroke or angina pectoralis(Dajnowiec and Langille, 2007; Hahn and Schwartz, 
2009). Though arteriogenesis and atherosclerosis arise from different conditions in the vasculature, 
they share several basic mechanisms. Through endothelial inflammation, endothelial proliferation and 
leukocyte recruitment take place(Hahn and Schwartz, 2009; Schaper, 2009), leading to outward 
remodeling in arteriogenesis and inward remodeling in atherosclerosis. Taken together, the data in 
Chapter III and from previous studies suggest that Shc is a central regulator of endothelial 
inflammation, that acts as a critical endothelial mechanotransducer in response to altered 
hemodynamics. It is likely that in vivo, Shc is necessary for transduction of signals generated by 
inflammatory hemodynamics, and for the initiation and continuation of endothelial inflammation. 
Under physiological hemodynamic regimes, Shc signaling is reduced, which coincides with a 
reduction in endothelial inflammation.  
 
 
FINAL PERSPECTIVES 
 The study of vascular inflammation is of major importance for the treatment and curing of 
vascular diseases. The data in this thesis, along with demonstrating the role of PECAM-1 in 
regulation of FN assembly and the role of Shc in inflammatory vascular remodeling, demonstrate that 
vascular inflammation cannot be fully understood without taking endothelial mechanosignaling into 
account. Shear stress causes two broad phenotypes in ECs: inflammatory and anti-inflammatory. If 
an overarching goal exists in the field of shear stress research, it is to understand the signaling 
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pathways and gene expression signatures of both endothelial phenotypes, and to exploit those 
differences for use in the design and delivery of vascular therapeutics. This thesis provides 
substantial insight into two known regulators of vascular inflammation: FN matrix, and the adaptor 
protein Shc. Considering both subjects together presents an interesting question about the origin of 
endothelial inflammation. Flow-induced FN expression is NF-κB-dependent(Feaver et al., 2010), and 
endothelial Shc is required for NF-κB activation in response to shear stress(Liu et al., 2008; Sweet et 
al., 2013), so it follows that inflammation may originate with Shc signaling, downstream of PECAM-1 
sensing altered hemodynamics. However, integrin ligation to FN is required for shear signaling 
downstream of integrins(Tzima et al., 2001), part of which includes Shc-dependent NF-κB activation, 
hence the uncertainty regarding the origins of endothelial inflammation. Regardless of the origins of 
inflammation, this thesis delves into signaling that sustains endothelial inflammation. This cascade is 
a positive feedback loop of inflammatory signals emanating from PECAM-1 and FN-bound integrins, 
integrated and processed by the adaptor protein Shc. Hopefully, the information contained herein, 
combined with many other studies, may provide a way to stop the inflammatory feedback that 
sustains the devastating vascular pathologies that plague human health. 
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Figure 4.1 Altered nitrosocysteine production in PECAM-1 KO mice 
 
WT and PECAM-/- mice were subjected to CAL and harvested at 24 hours, 5 days, or 3 weeks post-
CAL. (A) Cross sections of carotid arteries from WT and PECAM-1-/- mice were immunostained for S-
nitrosocysteine, followed by quantification of nuclear S-nitrosocysteine. (B) Representative images 
from WT and PECAM-1-/- mice from the sham and 3 week timepoints. (A) and (B) Sham: n=5 WT and 
4 PECAM-1-/- mice; 24 hours: n=5 WT and 4 PECAM-1-/- mice; 5 days: n=3 WT and 4 PECAM-1-/- 
mice; 3 weeks: n=4 WT and 3 PECAM-1-/- mice.   
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